key: cord-0864956-eyvph2kk
authors: Nash, Anthony A.; Dalziel, Robert G.; Fitzgerald, J. Ross
title: Chapter 8 Mechanisms of Cell and Tissue Damage
date: 2015-12-31
journal: Mims' Pathogenesis of Infectious Disease
DOI: 10.1016/b978-0-12-397188-3.00008-1
sha: fd29be5dd7dd4cd43c4280a059d7a85b873ab9ad
doc_id: 864956
cord_uid: eyvph2kk

Many infections are associated with damage inflicted either directly or indirectly by invading pathogens. Although some infections do not result in host damage, it is often a natural consequence of the activities of virulence factors produced by the pathogens in order to facilitate survival, and proliferation in the host or onward transmission to another host. The damage often manifests itself as the symptoms of disease which can be useful for diagnosis and for informing appropriate treatments. A wide array of different types of toxins which cause damage to the host are produced by different bacterial pathogens. Here we provide examples of well-characterised toxins and describe their mechanisms of action, and potential function with regard to pathogenesis. In addition we describe indirect damage to the host in the form of inflammation or immunopathology, typically the result of the host's own immune response. Finally, we discuss diarrhoea as a special case and list some of the major pathogens and the toxins associated with this devastating disease.

The damage inflicted by pathogens on their hosts is the result of direct and indirect collateral effects resulting from the activity of virulence factors performing specific functions involved in pathogenesis. It is the different types of damage caused which result in the symptoms of disease which allow diagnosis and implementation of appropriate treatment and control measures. The impact on the host of microbial damage depends very much on the tissue involved. Damage to muscle in the shoulder or stomach wall, for instance, may not be serious, but in the heart the very existence of the host depends on a strong muscle contraction continuing to occur every second or so, and here the effect of minor functional changes may be catastrophic. The central nervous system (CNS) is particularly vulnerable even to slight damage. The passage of nerve impulses requires normal function in the neuronal cell membrane, and viruses especially have important effects on cell membranes. Also a degree of cellular or tissue oedema that is tolerable in most tissues may have serious consequences if it occurs in the brain, enclosed in that more or less rigid box, the skull. Therefore, encephalitis and meningitis tend to cause more severe illness than might be expected from the histological changes themselves. Oedema is a serious matter also in the lung. Oedema fluid or inflammatory cell exudates appear first in the space between the alveolar capillary and the alveolar wall, decreasing the efficiency of gaseous exchanges. Respiratory function is more drastically impaired when fluid or cells accumulate in the alveolar air space. The effect of tissue damage is much less in the case of organs, such as the liver, pancreas or kidney, which have considerable functional reserves. More than two-thirds of the liver must be removed before there are signs of liver dysfunction.

Cell damage has profound effects if the endothelial cells of small blood vessels are involved. The resulting circulatory changes may lead to anoxia or necrosis in the tissues supplied by these vessels. Here too, the site of vascular lesions may be critical, effects on organs such as the brain or heart having a greater impact on the host, as discussed above. Rickettsiae characteristically grow in vascular endothelium and this is an important mechanism of disease production. By a combination of direct and immunopathological factors, there is endothelial swelling, thrombosis, infarcts, haemorrhage and tissue anoxia. This is especially notable in the skin and forms the basis for the striking rashes in typhus and the spotted fevers. These skin rashes, although important for the physician, are less important for the patient than similar lesions in the CNS or heart. It is damage to cerebral vessels that accounts for the cerebral disturbances in typhus; involvement of pulmonary vessels causes pneumonitis, and involvement of myocardial vessels causes myocardial oedema. For example, in Q fever, rickettsiae sometimes localise in the endocardium, and this causes serious complications.

Sometimes an infectious agent damages an organ, and loss of function in this organ leads to a series of secondary disease features. The signs of liver dysfunction are an accepted result of infections of the liver, just as paralysis or coma is an accepted result of infection of the CNS.

There are many diseases of unknown aetiology for which an infectious origin has been suggested. Sometimes it is fairly well established that an infectious agent can at least be one of the causes of the disease, but in most instances it is no more than a hypothesis, with little or no good evidence. For conditions as common and as serious as multiple sclerosis, cancer and rheumatoid arthritis, it would be of immense importance if a microorganism were incriminated, since this would give the opportunity to prevent the disease by vaccination or treat it with anti-microbials. For example, Borna disease (BD) has classically been described as a chronic, progressive meningoencephalomyelitis, causing both neurological and behavioural symptoms in horses and sheep. Experimental infection of tree shrews (Tupaia glis) with BD virus however results in very little overt disease, but afterwards the male is no longer able to enact the ritual courtship behaviour, which (as students well know) is an essential preliminary to mating in all primates. Thus it can be said that infection with BD virus renders the male psychologically sterile. Presumably the virus in some way alters the functioning of neurons concerned in this particular pathway. All other behavioural and physiological aspects appear normal. BD virus is not known to occur in man, but speculation about an analogous human situation is fuelled by the finding of BD virus-specific antibodies in patients with psychiatric/behavioural disorders. Since the aetiology of such diseases raises interesting problems in pathogenesis, the present state of affairs is summarised in Table 8 .1, which includes some of the human diseases whose infectious origin is probable, possible, conceivable or inconceivable.

Causal connections between infection and disease states are particularly difficult to establish when the disease appears a long time after infection. It was not too difficult to (Continued) prove and accept that the encephalitis that occasionally occurs during or immediately after measles was due to measles virus. But it was hard to accept that a very rare type of encephalitis (subacute sclerosing panencephalitis or SSPE), occurring up to 10 years after apparently complete recovery from measles, was also due to measles virus and this was only established after the eventual isolation of a mutant form of measles virus from brain cells. 'Slow' infections, in which the first signs of disease appear a long time after infection, are now an accepted part of our outlook. The disease Kuru occurred in New Guinea and was transmitted from person to person by ritual cannibalism. The incubation period in man appears to be 12À15 years, and the disease was caused by an infectious proteinaceous agent known as a prion that grew in the brain. This was established when the same disease appeared in monkeys several years after the injection of material from the brain of Kuru patients. A similar agent termed the scrapie agent infects sheep, cattle, mice and other animals and also has an incubation period representing a large portion of the lifespan of the host. In both Kuru and SSPE, the agent was eventually shown to be present in the brains of patients. If in a slow infection, the microorganism that initiated the pathological process is no longer present by the time the disease becomes manifest, then the problem of establishing a causal relationship will be much greater. This may possibly turn out to be true for diseases like multiple sclerosis and rheumatoid arthritis. Liver cancer in humans and certain leukaemias in mice, cats, humans and cattle can be caused by slowtype virus infections. Cancer or leukaemia appears as a late and occasional sequel to infection. The virus, its antigens or fragments of its nucleic acid are often detectable in malignant cells.

One important factor that often controls the speed of an infectious process and the type of host response is the rate of multiplication of a microorganism. Often the rate of multiplication in the infected host, in the presence of anti-microbial and other limiting factors, and when many bacteria are obliged to multiply inside phagocytic cells, is much less than the optimal rate in artificial culture. A microorganism with a doubling time of a day or two will tend to cause a more slowly evolving infection and disease than one that doubles in an hour or less (Table 8 .2).

It is uncommon for an infectious agent to cause exactly the same disease in all those infected. Its nature and severity will depend on infecting dose and route, and on the host's age, sex, nutritional status, genetic background and so on (see Chapter 11). Many infections are asymptomatic in more than 90% of individuals, clinically characterised disease occurring in only an occasional unfortunate host, as 'the tip of the iceberg'. Asymptomatically infected individuals who may continue to shed pathogen are important because they are not identified, move normally in the community, and play an important part in transmission. This chapter deals with demonstrable cell and tissue damage or dysfunction in infectious diseases. But one of the earliest indications of illness is malaise, or 'not feeling very well'. This is distinct from fever or a specific complaint such as a sore throat and, although it is difficult to define and impossible to measure, we all know the feeling. It can precede the onset of more specific signs and symptoms, or accompany them. Sometimes it is the only indication that an infection is taking place but almost nothing is known of the basis for this feeling. 'Toxins', of course, have been invoked and the early response to pyrogens before body temperature has actually risen and may play a part. Interferons may have something to do with it because pure preparations of human αor β-interferons cause malaise and often headaches, and muscle aches after injection into normal individuals. Soluble mediators of immune and inflammatory responses, such as interleukin-1 (IL-1; see Glossary) or other cytokines doubtless also play a part. Several cytokines induce release of prostaglandin E2 which, in addition to its effect on fever, reduces the pain threshold in neurons, and this could account for aches and pains.

Before giving an account of the mechanisms by which pathogens induce damage in the host, it is important to remember that many infectious agents cause little or no damage. Indeed, it is of some advantage to the microorganism to cause minimal host damage, as discussed in Chapter 1. Many virus infections fall into this category. Thus, although infection with rabies or measles viruses nearly always causes disease, there are many enterovirus, reovirus and myxovirus infections that are typically asymptomatic. Even viruses that are named for their common association with disease (poliomyelitis, influenza, Japanese encephalitis) may also be associated with infections in which an antibody response is the only sign of the presence of the pathogen, and tissue damage is too slight to cause detectable illness. There is a tendency for persistent viruses to cause no more than minor or delayed cellular damage during their persistence in the body, even if the same virus has a more cytopathic effect during an acute infection, e.g. adenoviruses and herpes simplex (see Chapter 10). A few viruses are remarkable because they cause no pathological changes at all in the cell, even during a productive infection in which infectious virus particles are produced. For instance, mouse cells infected with lymphocytic choriomeningitis (LCM) (see Glossary) or murine leukaemia virus show no pathological changes. The recently identified Torque Tenoviruses (TTVs) are ubiquitous in the human population and appear to establish persistent infections; however, no concrete association with any disease has been demonstrated. Throughout the life of the animal, virus and viral antigens are produced in the cerebellum, liver, retina, etc. without discernible effect on cell function. But sometimes there are important functional changes in infected cells which lead to a pathological result. For example, the virus infects growth-hormone-producing cells in the anterior pituitary. Although the cells appear perfectly healthy, the output of growth hormone is reduced, and as a result of this, suckling mice fail to gain weight normally and are runted.

As discussed previously, there are many millions of commensal bacteria which make up the microbiota, which serve important functions for their host. Of course, these bacteria are not typically involved in causing damage. Bacteria such as meningococci and pneumococci, whose names imply pathogenicity, spend most of their time as harmless inhabitants of the normal human nasopharynx: only occasionally do they have the opportunity to invade tissues and give rise to meningitis or pneumonia. However, when bacteria invade tissues, they almost inevitably cause some damage, and this is also true for fungi and protozoa. Some of the damage may not be severe in nature. For example, Treponema pallidum produces no toxins, does not cause fever and attaches to cells in vitro without harmful effects. Leprosy and tubercle bacilli eventually damage and kill the macrophages in which they replicate, but pathological changes are to a large extent caused by indirect mechanisms (see below). In patients with untreated lepromatous leprosy, the bacteria in the skin invade blood vessels, and large numbers of bacteria, many of them free, may be found in the blood. In spite of the continued presence of up to 10 5 bacteria/ml of blood, there are no signs or symptoms of septicaemia or toxaemia. Mycobacterium leprae can be regarded as a very successful parasite that induces very little host response in these patients, even when the bloodstream is invaded.

Cell and tissue damages are sometimes due to the direct local action of the microorganism. However, in many cases it is not clear how the death of cells results from virus infection. Virus infections result in a shutdown of RNA synthesis (transcription), protein synthesis (translation) and DNA synthesis in the host cell, but often these are too slow to account for the death of the cell. After all, cells like neurons never synthesise DNA, and the half-life of most proteins and even RNAs is at least several hours. A possible alternative mechanism is the alteration of the differential permeability of the plasma membrane. This is important as the cell has a high internal K 1 concentration and low Na 1 concentration, while the reverse is true of body fluids. Viruses do alter membrane permeability, but the unresolved question is whether or not this is responsible for the death of the cell or whether it is merely an after effect.

In many virus infections (including human immunodeficiency virus (HIV), adenoviruses, herpesviruses, influenza virus and picornaviruses), the cells commit suicide by a mechanism called 'programmed cell death' or 'apoptosis'. This is the natural process by which the body controls cell numbers and rids itself of superfluous or redundant cells during development. Cells do not disintegrate but round up and are then removed by phagocytes. Apoptosis in virus infections can be regarded as a host strategy for destroying infected cells. The chromatin condenses round the edge of the nucleus and a cellular endonuclease cleaves the DNA into 180À200 base pair fragments. The cell membrane forms blebs but stays intact while the cell as a whole breaks up into smaller bodies. The suicide process is more controlled, almost more dignified, than mere disintegration and necrosis. In the latter there is early loss of membrane integrity, spillage of cell contents and random break-up of DNA.

Some viruses encode proteins whose function is to inhibit apoptosis, so allowing the virus to replicate and new virions to be produced before the cell dies. Conversely some viruses appear to induce apoptosis, perhaps as a means of evading the immune response; apoptotic cells are not efficiently recognised by the immune system.

There are two more characteristic types of morphological change produced by certain viruses, and these were recognised by histologists more than 50 years ago. The first are inclusion bodies, parts of the cell with altered staining behaviour which develop during infection. They often represent either cell organelles or virus factories in which viral proteins and/or nucleic acids are being synthesised and assembled. Herpes group viruses form intranuclear inclusions, rabies and poxviruses intracytoplasmic inclusions, and measles virus both intranuclear and intracytoplasmic inclusions. The second characteristic morphological change caused by viruses is the formation of multinucleate giant cells. This occurs, for instance, when HIV 'fusion' proteins (gp120Àgp41) present on the surface of an infected cell attach to CD4 receptors in the plasma membranes of neighbouring cells; membranes then fuse and multinucleate cells are formed. This fusion mimics the fusion event that occurs when an enveloped virus binds to the surface of an uninfected cell and the virus membrane and cellular membranes fuse, so allowing entry of the virus genome and proteins to the cell. This cellÀcell fusion can also be observed following infection with paramyxovirus (measles, respiratory syncytial virus (RSV)) and certain herpes viruses.

Before leaving the subject of direct damage by viruses, one supreme example will be given. Here the direct damage is of such a magnitude that the susceptible host dies a mere 6 h after infection. If Rift Valley Fever virus, an arthropod-borne virus infecting cattle, sheep and man in Africa, is injected in very large doses intravenously into mice, the injected virus rapidly infects nearly all hepatic cells. Hepatic cells show nuclear inclusions within an hour and necrosis by four hours. As the single cycle of growth in hepatic cells is completed, massive liver necrosis takes place, and mice die only 6 h after initial infection. The host defences in the form of local lymph nodes, local tissue phagocytes, etc. are completely overcome by the intravenous route of injection, and by the inability of Kupffer cells to prevent infection of hepatic cells. Direct damage by the replicating virus destroys hepatic cells long before immune or interferon responses have an opportunity to control the infection. The experimental situation is artificial, but it illustrates direct and lethal damage to host tissues after all host defence mechanisms have been overwhelmed.

Most rickettsiae and Chlamydia damage the cells in which they replicate, and it is possible that some of this damage is due to the action of toxic microbial products. This action, however, is confined to the infected cell, and toxic microbial products are not liberated to damage other cells. Mycoplasma (see Table A .3) can grow in special cell-free media, but in the infected individual they generally multiply while attached to the surface of host cells. As studied in culture and on the respiratory epithelium, they 'burrow' down between cells, inhibit the beat of cilia and cause cell necrosis and detachment. The mechanism is not clear. If a complete lawn of mycoplasma covers the surface of the host cell, some effect on the health of the cell is to be expected, but it is possible that toxic materials are produced or are present on the surface of the mycoplasma. Intracellular bacterial pathogens generally damage the cells in which they replicate (see Chapter 4). Listeria, Brucella and Mycobacteria are specialists at intracellular growth, and the infected phagocyte is slowly destroyed as increasing numbers of bacteria are produced in it. Bacteria such as staphylococci and streptococci grow primarily in extracellular fluids but can also invade and proliferate in epithelial and endothelial cells. They are also ingested by phagocytic cells, and virulent strains of bacteria in particular have the ability to destroy the phagocyte in which they find themselves or can avoid killing and proliferate within the phagocytes, as described in Chapter 4. Many bacteria cause extensive tissue damage by the liberation of toxins into extracellular fluids. Various toxins have been identified and characterised. Most act locally, but a few cause pathological changes after spreading systemically through the body.

Dental caries provides an interesting example of direct pathological action. Colonisation of the tooth surface by Streptococcus mutans leads to plaque formation, and the bacteria held in the plaque utilise dietary sugar and produce acid. Locally produced acid decalcifies the tooth to give caries. Caries, arguably the commonest infectious disease of Western man, might logically be controlled by removing plaque, withholding dietary sugar, or vaccinating against S. mutans. However, fluoride in the water supply or in toothpaste has been the method of choice and has been very successful. It acts by making teeth more resistant to acid.

This is a huge and growing part of our subject and we need to define the term toxin, a task which is more difficult than one might think. An attempt was made by Bonventre who in 1970 defined toxins as a 'special class' of poisons which differ from, for example, cyanide or mercury by virtue of their microbial origin, protein structure, high molecular weight and antigenicity. This view is too embracing, because it includes proteins of doubtful significance in disease and also too restrictive, because it excludes non-protein toxic complexes such as endotoxin. Another suggestion is that toxin must include all naturally occurring substances (of plant, animal, bacterial or whatever origin) which, when introduced into a foreign host, are adverse to the well-being or life of the victim. This, too, is unsatisfactory because some substances À potent toxins within the scope of this definition À are being used in some contexts as therapeutic agents! Perhaps it is pointless to strive for an all-embracing definition, although the obvious differences between bacterial and fungal toxins warrant the continued use of the appropriate prefix. For example, bacterial toxins are usually of high molecular weight and hence antigenic, whereas fungal toxins tend to be low molecular weight and not antigenic.

The problem of definition is compounded because there are substances (aggressins) which help to establish an infective focus as well as those whose action is uniquely or largely responsible for the disease syndrome. Also there are substances known to be produced by bacteria in vitro, whose properties on a priori grounds make them potential determinants of disease, but which have not been shown to play a role in vivo.

For many toxins, there is considerable understanding of the genetic basis of toxin expression, secretion, assembly and activity, the resolution of the three-dimensional structure of toxins, and their biochemical modes of action. We now know a great deal about the spread of some virulence determinants in bacterial populations via bacteriophages and other transmissible genetic elements, the conditions under which toxins are expressed both in vitro and in vivo, how to disassemble complex protein toxins and form chimeric derivatives of known and potential use as therapeutic agents, and how to use some of the deadliest poisons known to man in treating certain physiological disorders. Elucidation of biochemical modes of action has resulted in toxins being used increasingly as important tools for the dissection of cell biological processes. Also, some new insights as to the role(s) of toxins in disease causation have been developed. The latter is the result of using isogenic toxin-deficient mutants in vivo, using more relevant biological test systems and concentrating more on the effects of sublethal doses of toxin and less on the effects of injecting a toxin bolus into some animal. It is beyond the scope of this book to attempt to cover all these subjects, so only an outline treatment will be given with some examples.

These are either secreted by or released upon lysis from both Gram-positive and Gramnegative bacteria, and historically referred to as exotoxins. They are proteins, some of which are enzymes. When liberated locally they can cause local cell and tissue damage. Those that damage phagocytic cells and are therefore particularly useful to the microorganism have been described in Chapter 4. Those that promote the spread of bacteria in tissues have been referred to in Chapter 5. A selection of some protein toxins follows.

Helicobacter pylori is a specific human pathogen affecting billions of people worldwide. It is transmitted via the orofaecal route and colonises the seemingly inhospitable niche of the stomach. Some 20% of infected patients can develop ulcers or stomach cancer. An essential virulence factor of H. pylori is a potent urease which is synthesised in vast quantity by the organism, and (at least in culture) released by autolysis and efficiently absorbed on to the surface of viable organisms. As noted in Chapter 2, it is important in local neutralisation of stomach acidity thereby allowing H. pylori to penetrate the protective mucus layer overlying the lining of the stomach where the organism attaches to gastric epithelial cells. However, urease is now considered by some as a toxin which acts outside cells, since NH 3 , the product of urease activity, is toxic to cells.

Proteases and hyaluronidases, which help the spread of bacteria through tissues, have already been mentioned in Chapter 5. Here we consider toxins which act on extracellular substances and are responsible for many of the main characteristics of the diseases caused by the infecting organism. Pseudomonas aeruginosa elastase, and one of at least six proteases of Legionella pneumophila, both induce fibrinopurulent exudation in the rat lung (a model for P. aeruginosa-induced pneumonia in human cystic fibrosis) and the guinea-pig lung (a model for legionnaires' disease), respectively. These characteristics almost certainly arise from the release of oligopeptides from extracellular matrix components of the host which are chemotactic for leucocytes and fibroblasts. The L. pneumophila protease is the same major secretory protein (the zinc metalloprotease) already considered in Chapter 4 in relation to survival within macrophages.

Staphylococcal exfoliative toxins (epidermolytic toxins) are important in staphylococcal bullous impetigo and 'scalded skin syndrome', a disease of newborn babies. The disease is characterised by a region of erythema which usually begins around the mouth and, in 1À2 days, extends over the whole body. The most striking feature of the disease is that the epidermis, although apparently healthy, can be displaced and wrinkled like the skin of a ripe peach by the slightest pressure. Soon large areas of epidermis become lifted by a layer of serous fluid and peel at the slightest touch. Large areas of the body rapidly become denuded in this way and the symptoms resemble those of massive scalding. The toxin causes cleavage of desmoglein 1, a desmosomal adhesion molecule (desmosomes are specialised cell membrane thickenings through which cells are attached to each other) in the stratum granulosum.

Some toxins destroy membranes by virtue of their proteolytic activities, and some by their ability to degrade lipid components, while others are pore-forming or detergent-like in their mode of action.

In addition to their action on protein components of lung connective tissue referred to above, P. aeruginosa elastase and the zinc metalloprotease of L. pneumophila are believed to destroy cell membranes by their proteolytic activity. This is the probable reason for the haemorrhage associated with lung infections caused by these pathogens, i.e. effects on type I alveolar epithelial and endothelial cells.

CLOSTRIDIUM PERFRINGENS α-TOXIN A large number of bacterial enzymes are phospholipases, some of which, but by no means all, are important toxins. A good example is the α-toxin of C. perfringens, the organism most commonly associated with gas gangrene. It is strictly anaerobic and occurs as a normal inhabitant in the large intestines of man and animals; its spores are ubiquitous in soil, dust and air. C. perfringens does not multiply in healthy tissues but grows rapidly when it reaches devitalised and therefore anaerobic tissues. This could be after contamination of a natural wound with soil or dust, particularly on battlefields or in automobile accidents, or after contamination of a surgical operation site with clostridia from the patient's own bowels or skin. After abortions, particularly in the old days before antibiotics, intestinal clostridia often gained access to necrotic or devitalised tissues in the uterus and set up life-threatening infections. Invasion of the blood was common and soon resulted in death, the clostridia localising and growing in internal organs such as the liver after death. C. perfringens has various enzymes that enable it to break down connective tissue materials, including collagen and hyaluronidase, thereby facilitating spread of the infection along tissue planes. Most of these enzymes are toxic to host cells and tissues, but α-toxin is easily the most important one. It is dermonecrotic, haemolytic (a feature seen mainly in tissues close to the focus of infection but sometimes responsible for large-scale intravascular haemolysis in infected patients), causes turbidity in lipoprotein-rich solutions and is lethal. While it is still true that these activities are all due to one molecular species, they are not (as was once thought) different expressions of the one enzymic activity.

Historically, C. perfringens α-toxin was the first bacterial toxin to be characterised as an enzyme: it is a zincmetallophospholipase C (PLC) which removes the head group, phosphoryl choline, from phosphatidyl choline and from sphingomyelin. It is of undoubted importance in gas gangrene. Toxoid prepared by formalin-treated toxin will protect sheep against infection caused by C. perfringens. The main basis of toxicity is the consequence of the ability of the α-toxin, in sublytic doses, to cause profound metabolic changes arising from release of phospholipid derivatives. The activation of the arachidonic acid cascade results in the production of leukotrienes (increasing vascular permeability), prostaglandins and thromboxanes (causing inflammation, muscle contraction and platelet aggregation). This toxin also upregulates expression of endothelial leucocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1) and neutrophil chemoattractant-activator IL-8, thereby impairing delivery of phagocytes to the site of infection. Clostridial illness can be mild or very severe according to the extent of bacterial spread, and the quantity of toxins that are formed and absorbed. Since the bacteria grow and produce their toxins only in devitalised tissues, the most important form of treatment is to remove such tissues. Clostridia are strictly anaerobic and exposure of the patient to hyperbaric oxygen (pure oxygen at 2À3 atmospheres in a pressure chamber) has been found useful in addition to chemotherapy.

Staphylococcal β-toxin (haemolysin) is a good example of a sphingomyelinase with an important role in virulence. It has activity on a number of different cell types including erythrocytes and may contribute to iron acquisition by release of haemoglobin from red blood cells. Recently, it has been reported to play a role on biofilm production by Staphylococcus aureus. It is noteworthy that in contrast to bovine mastitis strains of S. aureus, many human strains contain a bacteriophage encoding immune evasion factors inserted in the β-toxin gene resulting in loss of β-toxin expression. These data imply that beta toxin may be more important in some animal infections in comparison to humans.

A variety of bacterial pathogens produce specialised pore-forming toxins with an array of receptors, cell specificities and activities. Here we will discuss some selected examples.

CHOLESTEROL-BINDING CYTOLYSINS This is a large family of pore-forming toxins, also known as 'SH-activated cytolysins', made by many different species of Gram-positive bacteria, not all of which are pathogens. They are lethal, cardiotoxic, antigenically related, and their lytic and lethal activities are blocked by cholesterol. Interaction with cholesterol is thought to be the key primary event in their interaction with susceptible membranes, which leads to the impairment of the latter; cholesterol plays no further part in the subsequent damage process. However, the role of cholesterol has been interpreted in terms of mediating the oligomerisation process (illustrated in Figure 8 .1) which leads to membrane damage. Examples of cholesterol-binding cytolysins (CBCs) from pathogenic species include streptolysin O and S made by streptococci, perfringolysin O made by C. perfringens, listeriolysin made by Listeria monocytogenes, and pneumolysin (PLY) made by Streptococcus pneumonia. Despite the similarities which warrant their inclusion in the same toxin group, they play entirely different roles in disease causation by the organisms expressing these toxins. A good example to go into more detail is PLY.

This protein is produced by the pathogen S. pneumoniae (pneumococcus) which causes bacteraemia, pneumonia, meningitis and otitis media in humans. PLY is different from all other members of this group in that it is not actively secreted by the pathogen but remains in the cytoplasm until released by lysis of the pneumococcus. This toxin is a four-domain molecule which oligomerises and forms a pore after cholesterol binding. It possesses a 182 8. MECHANISMS OF CELL AND TISSUE DAMAGE number of different functions in pathogenesis and has haemolytic activity and induces inflammation of the lung conferring the ability to replicate in the lung and invade the bloodstream, and altering alveolar permeability, also inhibiting cilial beat in respiratory mucosa. An important function is the activation of the classical pathway of complement which presumably assists evasion of complement activity directed towards bacterial cells. PLY can influence the expression of a number of host genes and multiple host-associated signal transduction pathways and is considered to be a neurotoxin. PLY has also been implicated in causing sensorineural deafness associated with meningitis caused by the pneumococcus (Figure 8 .2).

Associates with membrane

Toxin pore Aggregation on cell surface Aggregation Insertion FIGURE 8.1 Pore formation by pore-forming toxins. Newly synthesised proteins are soluble. On interaction with cell membranes they undergo conformational changes which allow reorganisation on and insertion into target cell membranes. Cholesterol is involved as primary receptor or mediator of aggregation for the CBC group. Others have specific receptors, but staphylococcal δ-toxin does not. Reproduced with permission from Mitchell et al., 1992, Figure 1. Attempts to develop protective anti-pneumococcal vaccines have hitherto been based on the type-specific capsular polysaccharides. Unfortunately, there are at least 90 known types and current vaccine preparations comprise a blend of polysaccharides from some 23 types. Currently, efforts to develop a broadly effective vaccine based on genetically engineered PLYs fused to other S. pneumoniae antigens are demonstrating some promise.

RTX TOXINS This group of toxins has been designated RTX (repeats in toxin) toxins by virtue of a common structural feature À the presence of an array of a nine amino acid repeat (ca. 10À40) to which Ca 21 binds thereby activating the toxins which form membrane pores of varying sizes. They constitute the largest group of bacterial pore-forming toxins and are widespread among Gram-negative pathogens. In general, the role of RTXs in disease is not clear but three examples are given where RTXs are important. Escherichia coli α-haemolysin, regarded as the prototype of this group, is important in extraintestinal infections caused by this organism; the toxin is active against a broad range of mammalian cells. Leukotoxin from Pasteurella haemolytica exhibits narrow target cell and host specificities; it specifically kills ruminant leucocytes and is important in bovine pneumonic pasteurellosis. The third example is the 'invasive' adenylate cyclase toxin of Bordetella pertussis. This toxin is unique among this group in that it is a large bifunctional toxin: it has both haemolytic (Hly) and adenylate cyclase (AC) activities, hence the designations AC-Hly, AC toxin, CyaA, and is known to be important in the early stages of respiratory tract colonisation. Strictly it is the haemolysin part of the molecule which belongs to the RTX family and its main function appears to be in translocation of the AC moiety into the cell where cAMP levels are elevated with ensuing pathophysiological sequelae.

STAPHYLOCOCCAL α-TOXIN Staphylococci produce a range of toxins, some of which we have already met. The α-toxin is easily the most studied from a biophysical point of view and is considered the main cytolysin produced by S. aureus. Like streptolysin O and staphylococcal δ-toxin, it is secreted as a water-soluble protein and undergoes self-induced oligomerisation on cell membranes to form heptameric pores. Recently, the receptor for α-toxin was identified as a disintegrin and metalloprotease 10 (ADAM-10) molecule, which upon binding relocate to calveolin-enriched lipid rafts which lead to clustering of signal molecules. Ultimately the interaction leads to upregulation of ADAM-10 metalloprotease activity leading to the cleavage of E-cadherin and disruption of epithelial barrier function. This in turn leads to acute lung injury. The toxoid (inactive) version of α-toxin is currently being examined as a potential vaccine.

DETERGENT-LIKE TOXINS Phenol soluble modulins (PSMs) represent a new family of staphylococcal toxins which include the classical staphylococcal δ-toxin involved in various aspects of pathogenesis. PSMs are amphipathic alpha helical peptides with their own unique secretory transport system, and they have potent activity on neutrophils after phagocytosis, and contribute to biofilm formation, dissemination, colonisation and interspecies competition. Of note, δ-toxin has recently been shown to exacerbate the symptoms of atopic dermatitis by binding and activating mast cells.

BINARY TOXINS These comprise two proteins, only one of which is toxic but the other is necessary at some stage for manifestation of toxicity. A good example is the staphylococcal leukocidins which belong to a very large family of binary leukocidins. Each leukocidin consists of two proteins À S (so called because it elutes slowly) and F (it elutes fast) from an ion-exchange column. S binds first to cell receptors, several of which have been recently identified (important in defining target cell specificity), followed by F which acts synergistically with S to create functional pores in the target membrane. There are at least six class S proteins and five class F proteins which can give rise to ca. 30 biologically active combinations, a fact which could be highly significant in that some strains produce more than one binary leukocidin. Although various SÀF combinations exhibit different target cell specificities, most are active against PMNs. For example, PantonÀValentine leukocidin is highly active against human PMNs binding to the human complement receptor C5aR and causes release of leukotriene B4, IL-8, histamine and tissue degradative enzymes, which likely accounts for some of the respiratory tissue damage and severe symptoms associated with necrotising pneumonia. In addition leukocidin ED binds to the CCR5 receptor on neutrophils and T-lymphocytes, leading to disruption of phagocytosis which promotes survival in mouse models of infection.

Many toxins have intracellular targets. There is intense interest in seeking to understand the mechanism(s) of uptake of the active moieties of toxins whose targets are intracellular. This is driven by the desire to understand fundamental mechanisms in cell biology and to develop selective 'cytotoxic therapies' in clinical medicine as well as to unravel the molecular mechanisms of disease causation. To reach an intracellular target, a protein must first be translocated across the cytoplasmic membrane. There are at least three ways in which this can be achieved: self-translocation across cytoplasmic membrane, direct injection and receptor-mediated endocytosis.

The best example of self-translocation across cytoplasmic membrane known to date: the invasive adenylate cyclase of B. pertussis described above.

A good example is the P. aeruginosa exoenzyme S (PES). PES is a single polypeptide with no receptor-binding component or translocation domain (see below): it is 'injected' directly across cell membranes by a mechanism functionally similar to that already described for the translocation of Tir by E. coli (see Chapter 2). PES is activated by a cytoplasmic protein FAS, and ADP-ribosylates by the small G-protein Ras resulting in the collapse of the cytoskeleton (see Chapter 4).

There are several variations on the receptor-mediated endocytosis theme reflecting the structure of the toxins; in some cases the process involves the subversion of normal processes used by the host cell to regulate movement and organisation of cellular membranes and substituent components. Toxins first bind to their respective receptors and become internalised via coated pits, vesicles or caveolae, into endosomes from which they still must escape into the cytoplasm.

Three types of toxin with intracellular targets have been recognised, reflecting their genetic origin. Some toxins consist of a single peptide, the product of a single gene, which undergoes post-translational modification into A and B fragments which are covalently linked (Figure 8 .3). The A fragment is the 'active' toxiphore and the B fragment bears the receptor-binding domain and also mediates translocation of A into the cytoplasm. A second group of toxins are the products of separate genes, giving rise to A and B subunits which non-covalently associate into stable complexes. They are also designated AÀB type toxins, in which the number and nature of B subunits vary, but the connotations of A and B are as for DT. Examples include classical cholera toxin (CT), E. coli heat labile enterotoxins (LTs), pertussis toxin (PT), Shiga toxin (ShT) and Shiga-like toxin (ShLT) (Figure 8.4) .

A third group of toxins are the products of separate genes giving rise to different proteins which are functionally equivalent to A and B subunits. These proteins do not associate into stable complexes but must act in concert to express toxicity and are known as binary (or bi-component) toxins. Examples include anthrax toxins and Clostridium botulinum C2 toxin (Figure 8 .4).

DIRECT ESCAPE FROM ENDOSOME DT B fragment binds to its receptor (a precursor of heparin-binding epidermal growth factor (EGF)-like growth factor), undergoes conformational change in the acidified endosome and inserts into the endosomal membrane, pulling the C terminus of the A fragment across the membrane. The aSaSabridge is exposed to the cytosol, reduced, thereby freeing A to enter the cytosol (Figure 8 .6). A similar mechanism operates with anthrax lethal factor (LF) and oedema factor (EF) toxins but in this case a third protein, protective antigen (PA), acts as the functional equivalent of DT B (Figure 8 .7).

For most if not all other toxins the route to an intracellular target is much more complex. Newly formed toxin-containing endosomes enter those vesicular trafficking pathways which lead to the trans-Golgi network (TGN), through the Golgi and further into the endoplasmic reticulum (ER). Using the example of CTA, in the Golgi apparatus, the A1 protein is recognised by the ER chaperone, protein disulfide isomerase, unfolded and delivered to the membrane, where the ER-oxidase-Ero1 synthesised as a single polypeptide but is cleaved (nicked) by proteases into two fragments designated A and B, held together by an aSaSabond. The latter is reduced during translocation of the A fragment into the cytosol. The B fragment consists of a receptor domain (R) which recognises the DT receptor À an EGF-like precursor which happens to be widely distributed throughout all organ systems À and a T domain which facilitates the translocation of A into the cytoplasm (see Figure 8 .4).

triggers the release of the A1 protein. As the A1 protein moves from the ER into the cytoplasm by the Sec61 channel, it refolds and avoids deactivation as a result of ubiquitination. The C-terminal sequence lysineÀaspartateÀglutamateÀleucine (the KDEL motif) in the A subunit of CT and related sequences in LT and PEA, is normally found in proteins which, having been processed in the Golgi, are returned to and are trapped by the ER which recognises the KDEL motif, thereby preventing such proteins being lost to the cell via exocytotic trafficking. Then, either in the TGN or the ER, CTA is reduced, freeing CTA 1 , the DT is synthesised as a single peptide (see Figure 8 .3). CT is represented in plan and elevation views; E. coli LTs are structurally and functionally very similar to CT. CTA comprises CTA1ÀA2. A1 is the toxiphore which is held in association with B via A2. A2 has no known enzymic activity but plays some as yet undefined part in toxicity. Differences in CT A2 and LT A2 have been implicated as part of the reason for the lesser severity of disease caused by ETEC. PT B subunits are heterogeneous. Botulinum C2 toxin is a two-component binary toxin, in which two proteins do not form stable complexes prior to cell attachment. Not to scale. Modified with permission from Madshus and Stenmark, 1992, Figure 1 .

CT toxiphore (Figure 8 .4). CT is activated by ADP-ribosylating factors (ARFs) which are also known to be involved in vesicular trafficking. Thus, by anterograde transport (the term given to secretory pathways from ER to the plasma membrane), CTA 1 may well be ferried in vesicles to the basolateral membrane with which they fuse, thereby depositing CTA 1 near to the target, adenylate cyclase ( Figure 8 .8). 

The targets for some of the intracellular toxins are listed in Table 8 .3, and illustrated in Figures 8.9À8.13.

The superantigen group of toxins represent a large family of strain-dependent toxins made mostly by S. aureus and Group A streptococci. To date at least 23 different members of the family have been identified among S. aureus isolates alone. While most S. aureus interacts with the cell membrane and forms heptameric oligomers. After proteolytic cleavage, PA sites are exposed which bind EF, thereby facilitating translocation of EF into the cytosol directly from acidified endosomes as described for DTA (Figure 8 .6). EF must be rapidly inactivated since washing toxin-treated cells results in a rapid loss of adenylate cyclase activity. EF interacts with calmodulin (CAL) to become an active adenylate cyclase enzyme in nearly all cells. Interaction of PA with EF and subsequent internalisation of EF is blocked by prior binding of LF. In contrast to EF which is active in many cells, LF protease is only active in macrophages. This model explains the characteristic hypovolaemic shock syndrome (cAMP is a potent secretagogue), cytotoxicity to macrophages, and the immunogenicity of PA.

superantigens are encoded on mobile genetic elements and are therefore found only in a subgroup of strains, one recently identified superantigen known as SElX is encoded in a stable region of the genome and is therefore made by the great majority of strains. The toxins are superantigens by virtue of their ability to bind to major histocompatibility (MHC) class II molecules, outside the antigen-binding grove. They are presented as unprocessed proteins to certain T lymphocytes expressing specific T-cell receptor (TCR) motifs located in the variable domain of the β-chain (Vβ) of the TCR (see Chapters 6 and 7). Nanogram to picogram quantities of superantigen will stimulate up to 20% of all T cells, compared with only 0.001À0.00001% T cells stimulated by conventional presentation of antigen to TCR. As a consequence of this huge proliferation of T cells and expression/release of aberrantly high levels of cytokines and other mediators, many biological systems are affected causing lethality/shock. This represents an important interference with a coordinated immune response, and the widespread polyclonal activation and cytokine release can be regarded as a microbial strategy, a 'diversion' of host immune defences. Ironically, the superantigen not only expands the circulating T-cell population but also reacts with developing T cells in the thymus, causing the same subpopulation to decline (see Chapter 7). It seems probable that these effects on immune cells represent a more important biological function of these toxins than the one responsible for the characteristics of disease; the latter may be no more than an 'accidental' phenomenon. For example, it may be that superantigens' main role is to subvert the T-cell response in localised infections leading to immune avoidance and persistence. It turns out that similar molecules are formed by Yersinia, mycoplasma and by certain retroviruses (e.g. the Mls antigen of mouse mammary tumour virus). It has been shown experimentally (or proposed) that immune stimulation, cytokine release, induction of capillary leak, shock and lethality are related to the superantigenicity This represents a much more complex route to an intracellular target. As described in the text it involves interaction of CTB subunits (shaded part of molecule) with ganglioside receptor GM1 (vertical arrow), receptor-mediated endocytosis, retrograde transport of the endosome to the TGN, through the Golgi to the ER, and anterograde transport of liberated CTA1 from ER in vesicles directed to the basolateral membrane, the intracellular location of adenyl cyclase. This mechanism is operative at least for several other toxins. of these proteins. However, there are other biological activities of these toxins which are not mediated by their superantigenicity. Some of these activities are common to all, and others specific to certain members of this group. The red skin rash elicited by the streptococcal toxins (which gave rise to the original nomenclature 'erythrogenic' toxins) is regarded as a secondary hypersensitive effect, but pyrogenicity is the result of direct action on the hypothalamus as well as release of IL-1 and TNF-α from macrophages. Staphylococci cause food poisoning on a worldwide scale but particularly in countries such as France which consume large quantities of unpasteurised cheese. Infection rates are under-reported, probably because it is normally a self-limiting gastrointestinal disease. Onset of disease is rapid after consumption of food contaminated with a subgroup of the superantigen family (enterotoxins) which have emetic activity (capacity to induce vomiting). The main features of the disease are diarrhoea and severe vomiting, the latter being due to enterotoxin stimulation of the vagus nerve.

In addition, some strains of S. aureus cause toxic shock syndrome (TSS), a multisystem disease. Originally, TSS was seen characteristically in menstruating women whose tampons Pertussigen will catalyse the ADP-ribosylation of G proteins involved in several transmembrane signalling events. d C. perfringens and C. spiroforme toxins and C. difficile ADP-ribosyltransferase form an iota subgroup, in that antibodies will cross-react within this group but not with C. botulinum C2 toxin. Only within the iota group are the binding components interchangeable. The iota group will also modify all mammalian actin isoforms.

Adenine Ribose-P-P-ribose Ribose-P-P-ribose DT Adenine CONH 2 CONH 2 NAD Target protein + + + N + N + FIGURE 8.9 ADP-ribosylation reaction. This enzymic reaction is common to a wide range of toxins with different target proteins (see Table 8 .3). elongation and illustrates the key role played by two enzymes, EF-1 and EF-2. EF-1-GTP interacts with aminoacyl-tRNA; this complex is docked into site A, EF-l-GTP becomes EF-1-GDP and is recycled as shown. After peptidyl transfer, EF-2-GTP catalyses transfer of the extended peptide to site P, and is itself autocatalytically converted to EF-2-GDP. DTA and PEA each ADP-ribosylates diphthamide (a modified histidine) in EF-2-GTP, which can no longer translocate the newly elongated peptide from the A site to the P site. The ShTA fragment is a specific N-glycosidase which cleaves an adenine residue from near the 3 0 end of the 28S ribosomal RNA. This depurination results in failure of EF-1-dependent binding of aminoacyl-tRNA to site A and hence inhibits protein synthesis. Poliovirus achieves selective inhibition of host protein synthesis at an earlier stage than is depicted here. Host mRNA is first modified (capped), then bound to the small ribosomal subunit; poliovirus mRNA is not capped. The function of a capbinding protein, which recognises and binds host mRNA to the ribosome, is inhibited by a poliovirus virion protein thereby allowing differential translation of virus messenger RNA. EF-1α, nucleotide-binding protein; EF-1αβγ, nucleotide exchange protein. harboured multiplying staphylococci. It is due to a toxin called toxic shock syndrome toxin 1 (TSST-1). TSS is characterised by sudden onset of fever, vomiting, diarrhoea, an erythematous rash followed by peeling of the skin, hypotensive shock, impairment of renal and hepatic functions and occasionally death. We now know that TSS is not confined to menstruating women. Non-menstrual TSS presents with essentially the same signs as menstrual TSS and is caused by other staphylococcal enterotoxins (SEs). TSST-1 is isolated only from menstrual cases of TSS: this toxin has the ability to cross the vaginal mucosal barrier whereas the other SEs do not. Streptococcal TSS (STSS), a life-threatening disease caused by streptococci, is also a well-recognised clinical entity, probably corresponding to the severe cases of scarlet fever described in the older literature.

It is important to point out that, while the outstanding advances made in our knowledge of toxin structure and mode of action at the cellular level can be exploited in a remarkable way (see below), it is important to remember that such knowledge by itself does not tell the whole story of the pathogenesis of infectious disease. To illustrate this some examples are given below.

It is obvious from our consideration of these toxins that the elucidation of their lytic activities towards red cells in terms of a fundamentally similar mechanism, by itself tells us nothing about their respective roles in disease. Moreover, as already outlined above, PLY is now known to be a multifunctional molecule whose relevance in disease varies with the infection setting!

C. diphtheriae produces DT which is of unquestionable importance in causing diphtheria. Sustained active immunisation with DT toxoid has made diphtheria a clinical rarity in advanced countries. Failure to continue this policy resulted in a huge diphtheria epidemic in the early 1990s in the states comprising the former USSR. C. diphtheriae organisms multiply on the epithelial surfaces of the body (nose, throat, skin) but do not penetrate deeply into underlying tissues. The infection on the body surface causes necrosis of mucosal cells with an inflammatory exudate and the formation of a thick 'membrane' (hence the name C. diphtheriae: Gr., diphthera 5 membrane) and if the infection spreads into the larynx there may be respiratory obstruction. The toxin probably assists colonisation of the throat or skin by killing epithelial cells and polymorphs. DT can also be disseminated from the infection site and has important actions, especially on the heart and nervous system. The toxin is encoded by a lysogenic corynephage β whose transcription is controlled by an irondependent repressor, emphasising the importance of C. diphtheriae Fe metabolism in vivo.

Shigella dysenteriae 1 is the cause of bacillary dysentery. For a long time it was thought that ShT was the principal cause of this disease. However, in Chapter 2, the importance of gut invasiveness in Shigella infections was emphasised. While it is not at all clear how ShT can be involved in the watery diarrhoea phase of dysentery, it is perceived as exacerbating the bloody diarrhoea phase rather than initiating it. In contrast there is now evidence that ShLTs are important in haemorrhagic colitis (HC) and haemolytic urea syndrome (HUS) caused by ShLT-producing strains of enterohaemorrhagic (EHEC) E. coli: EHEC has the capacity to progress disease beyond a watery diarrhoea stage to HC and HUS; the latter is characterised by renal failure, thrombocytopenia and microangiopathic haemolytic anaemia. This virulence attribute is due to possession of one or more of a family of ShLTs. As in dysentery, the role of ShLT in the causation of watery diarrhoea is controversial and indeed it may not be absolutely necessary. Importantly, the normal reservoir for EHEC is not humans but the terminal rectum of the cow, where it colonises without causing clinical symptoms of disease. This suggests that the potent effects of ShLT made by EHEC causing infections of humans are unlikely to be the main purpose of their expression and that there is likely to be another less pathological role in its main niche. This may involve promotion of colonisation through subtle effects on the local bovine gut epithelium.

The classic paradigm for bacterial watery diarrhoea is cholera caused by V. cholerae in the small intestine. V. cholerae colonises the upper small intestine by adhering to epithelial cells. Water and electrolytes are lost through the intact epithelial cells into the small intestine. As the multiplying bacteria increase in numbers and more and more epithelial cells are affected, the absorptive capacity of the colon is overwhelmed and there is profuse watery diarrhoea, as much as 1 l/h in severe cases. The massive loss of isotonic fluid with excess of sodium bicarbonate and potassium leads to hypovolaemic shock, acidosis and haemoconcentration. Anuria develops, and the collapsed, lethargic patient may die in L FIGURE 8.11 Mode of action of CT, E. coli LT toxins and pertussigen (PT). There are five main features in this diagram. 1. The production of cAMP by adenyl cyclase. Cyclic AMP is an important second messenger involved in the intracellular amplification of many cellular responses to external signals including hormones. The nature of the physiological response reflects the differentiation of the cell responding to the stimulus. For, example, in gut cells the response would be altered ion transport and hence fluid secretion; in muscle cells it would be glycogen breakdown in response to the call for more energy. The production of cAMP is controlled both positively (a) and negatively (b) at two levels. Interaction of hormone and receptor releases the heterotrimeric (αβγ) G-protein regulator complex which, upon binding GTP, dissociates into α-GTP and βγ. The α-subunit may be stimulatory (α s ) and activate adenyl cyclase (as in (a)) or inhibitory (α i ) and inhibit adenyl cyclase (as in (b)); adenyl cyclase is not shown structurally in the diagram. In gut cells the receptor would be on the nonluminal basolateral side enabling enterocytes to respond to stimuli from the circulation. 2. The second level of control involves endogenous GTPase properties of both α s and α i subunits of the G-protein regulator: α s -GDP and α i -GDP are inactive. 3. The level of cAMP may be affected by physiological stimuli or by perturbation of the normal regulatory cycle as illustrated, by CT and LTs in enterocytes (a) or PT in a pancreatic B cell (b). 4. CTA1 ADP-ribosylates α s -GTP which promotes continued dissociation of the heterotrimer and also inactivates the endogenous GTPase activity. Hence stimulation of the cyclase continues. LTs act in a similar manner. 5. PTS1 ADP-ribosylates the α i -GDPβγ-heterotrimer which can no longer associate with the receptor or lose GDP to undergo another cycle of GTP activation; active cyclase can no longer be turned off. In pancreatic cells this results in loss of inhibition of insulin secretion.

Note: the α-GTP subunits are functionally analogous to the monomeric GPTases described in Muscles are reciprocally innervated with sensory and motor neurons, although for clarity this is shown only for the protagonist muscle. On stretch, the stretch receptors generate an impulse which is transmitted along the afferent sensory (S) neuron of the protagonist (P) muscle. This SP neuron enters the spinal cord by the dorsal root and synapses with the motor neuron supplying the protagonist muscle (MP) and with an interneuron (I) which in turn synapses with the motor neuron supplying the antagonist muscle (MA); the efferent motor neurons leave the spinal cord by the ventral root. At the SP/MP synapse an excitatory transmitter is released which induces an impulse in MP which leads to contraction of protagonist muscle. However, excitation of I causes release of an inhibitory transmitter at the I/MA synapse which leads to relaxation of the antagonist muscle. Note that the basic reflex arc has been shown for simplicity but TeTx acts mainly on voluntary muscles.

synapses, neurotransmitter release and action. Gly, glycine; R, receptors of neurotransmitters; X, hitherto uncharacterised (candidates include glutamate, dopamine, ATP, substance P, and somatostatin). 3. Sites of neurotoxin action (lower left and right). The predominant site of action of TeTx is the intermotor neuron synapse; the exocytotic machine is interfered with by the endopeptidase action of TeTx on VAMP. BoNT acts at the neuromuscular junction, inhibiting the release of acetyl choline (Ach) by its proteolytic action on VAMP (types B, D and F), or SNAP (types A and E), or syntaxin (type C).

Amplified from Stephen and Pietrowski, 1986, Figures 18 and 19. 12À24 h. Lives are saved by replacing the lost water and salts, but the patient recovers as affected cells are shed and replaced in the normal fashion. The infection is particularly severe in children who easily develop low levels of plasma potassium. However, on a global scale this greatly feared disease, cholera, is only responsible for less than 1% of the total deaths due to diarrhoea. The genome of V. cholerae contains genetic elements which are important in V. cholerae virulence: CTXφ (the genome of a filamentous bacteriophage) which encodes the CT, and a large pathogenicity island VPI (for V. cholerae pathogenicity island). VPI is the integrated genome of another large filamentous bacteriophage (VPIφ) and encodes the toxin coregulated type IV gilus (Tcp). Of the numerous colonisation factors known to be produced by V. cholerae, only Tcp has been proven to be important in human disease. Tcp is a remarkable entity; its subunit TcpA is a coat protein of VPIφ, but it also acts as a receptor for CTXφ and mediates interbacterial adherence. Thus, as a result of sequential infection by two 'pathophages', V. cholerae acquires the ability to colonise the human gut and secrete classical CT, which is a potent enterotoxin. The integration into the chromosome of these phage genomes brings their expression under the control of regulatory genes in the the cell membrane followed by C2I. The latter is internalised and upsets the equilibrium between polymerisation and depolymerisation of actin. ADP-ribosylation of actin inhibits its polymerisation and turns G-actin into a capping protein which binds to the fast-growing (concave) ends of actin filaments. Capping of the concave ends increases the critical concentration for actin polymerisation. Since the slow-growing (pointed) ends of actin filaments are free, depolymerisation of actin occurs at these ends. Released actin is substrate for the toxin and will be withdrawn from the tread-milling pool of actin by ADP-ribosylation, i.e. trapped. Both reactions will finally induce the breakdown of the microfilament network. Reproduced with permission from Aktories et al., 1992, Figure 2. ancestral chromosome, whilst the replication of phages enables their interbacterial spread. CT is an 'AB'-type toxin in which the pentameric B subunit recognises and binds to its cell receptor (GM1 ganglioside) thereby initiating the internalisation of the active A subunit (CTA 1 ) and elevation of cAMP.

Studies on human jejunal biopsies show that cholera is not a purely pathophysiological disease but a pathological one, involving changes in the microvasculature and enteric nerve fibres, degranulation of argentaffin cells, mucosal mast cells and eosinophils; the extent of these changes correlated with clinical severity of disease. Despite the undoubted importance of CT in the causation of the disease, and the potent antigenicity of CT, it is now recognised that a large number of other virulence determinants are involved, and that protective immunity is very largely antibacterial. It is stopping effective colonisation which is important rather than neutralisation of the toxin. This has been partially achieved by using killed whole cell vaccines. Several attempts have been made in the laboratory to manipulate virulent strains genetically (in practice this means deleting or inactivating the known toxin genes) such that the attenuated strain will colonise the gut and stimulate local immune responses, and thereby prevent colonisation of the gut by virulent strains. To date, attenuated strains have been developed which fulfil these criteria, but these induce a mild transient diarrhoea, which has prevented their adoption into vaccination programmes. The most widely used current vaccine is an oral one which includes a combination killed bacteria (bacterin) and CT B subunit.

Whooping cough (pertussis) is a severe respiratory tract infection characterised by prolonged paroxysmal coughing, attacks of which continue long after infection has cleared. The disease is capable of striking all ages but is particularly prevalent and severe in young children, where hospitalisation is required in about 10% of cases. The causative agent, B. pertussis, is transmitted aerially from the respiratory tract of an infected individual to that of a susceptible host. The organism attaches via several adhesins À filamentous haemagglutinin, fimbriae and the 69 kDa outer-membrane protein, pertactin À to the mucosal surface between cilia, and multiplies there during the incubation period of the disease, which is commonly around seven days. The infection then manifests as a slight fever and catarrh which is often indistinguishable from a common cold. However, 1À2 weeks later bouts of uncontrollable coughing begin. It is this paroxysmal coughing, along with the notorious 'whoop' as the child attempts to draw breath, which characterises the disease. The paroxysmal coughing stage often lasts for several weeks and no treatment is fully effective in controlling the symptoms. The only proven means of controlling whooping cough is vaccination but, in the United Kingdom at least, sporadic reports of vaccineinduced brain damage in infants has diminished public acceptance of the vaccine. However, it should be noted that permanent encephalopathy (brain damage) is a recognised though rare consequence of whooping cough infection.

Without doubt, pertussigen (PTx), whose biochemical mode of action is described above, is an exceedingly important virulence determinant of B. pertussis: PTx toxic activities including histamine sensitisation, hyper-insulinaemia followed by hypoglycaemia, induction of leukocytosis and IgE induction are all observed after infection and administration of PTx; these toxic properties of PTx are abolished when the ADPR activity of PTx 200 8. MECHANISMS OF CELL AND TISSUE DAMAGE is inactivated. PTx non-toxic activities À mitogenicity, haemagglutination, platelet activation, mucosal adjuvanticity À are triggered by PTx B subunits. Much current work is being devoted to producing immunogenic, completely non-toxic preparations of PT by genetic manipulation of the gene encoding the S1 subunit (Figure 8.4) ; in clinical trials in Italy, such engineered vaccines have been shown to be both safe and effective.

However, B. pertussis also produces other potentially important toxins including AC-Hly involved in colonisation (see above), dermonecrotic toxin (DNT; formerly known as heatlabile toxin), and two non-protein toxins À trachéal cytotoxin (TCT) and endotoxin. DNT is lethal for mice and causes skin lesions in rabbits and guinea pigs. It is of doubtful significance in humans but important in atrophic rhinitis in pigs caused by Bordetella bronchiseptica 1 . TCT is a small glycopeptide which destroys ciliated epithelial cells and is almost certainly responsible for some of the observed histopathological damage in B. pertussis infections.

Tetanus occurs in man and animals when Clostridium tetani spores germinate in an infected wound and produce their toxin; all strains of C. tetani produce the same toxin. Spores are ubiquitous in faeces and soil and require the reduced oxygen tension for germination provided locally in the wound by foreign bodies (splinters, fragments of earth or clothing) or by tissue necrosis as seen in most wounds, the uterus after septic abortion, or the umbilical stump of the newborn. The site of infection may be a contaminated splinter just as well as an automobile or battle injury. It also reaches the CNS by travelling up other peripheral nerves following blood-borne dissemination of the toxin through the body. The B part of the toxin binds to dissialogangliosides (GD2 and GD1b) on the neuronal membrane and movement of the protein across that membrane into the neuron is promoted by the presence of a translocation domain. The motor nerves in the brainstem are short and therefore the cranial nerves are among the first to be affected, causing spasms of eye muscles and jaw (lockjaw). There is also an increase in tonus of muscles round the site of infection, followed by tonic spasms. In generalised tetanus there is interference with respiratory movements, and without skilled treatment the mortality rate is about 50%. Botulism 2 is caused by C. botulinum, a widespread saprophyte present in soil and vegetable materials. C. botulinum contaminates food, particularly inadequately preserved meat or vegetables, and produces a powerful neurotoxin. The botulinum toxin is destroyed at 80 C after 30 min À of great importance to the canning industry À and there are at least seven antigenically distinct serotypes (A-G) produced by different strains of bacteria but which have a pharmacologically similar mode of action. It is absorbed from the intestine and acts on the peripheral nervous system by binding to the synaptic vesicle protein SV2 on neurons, interfering with the release of acetylcholine at cholinergic synapses of neuromuscular junctions. Somewhere between 12 and 36 h after ingestion there are clinical signs suggesting an acute neurological disorder, with vertigo, cranial nerve palsies and finally death 1 DNT is similar to the dermonecrotic toxin of Pasteurella multicoda also involved in porcine atrophic rhinitis. They inactivate the GTPase activities of Rho proteins, resulting in cytoskeletal changes affecting osteoblasts. a few days later with respiratory failure. A less typical form of botulism occurs in small infants. The spores, present in honey applied to rubber teats, appear to colonise the gut, so that the toxin is produced in vivo after ingestion. The high potency of botulinum toxins and the specificity and reversibility has found numerous applications in the treatment of various clinical syndromes and cosmetically for the reduction of facial wrinkling (Botox).

Anthrax is a disease of animals, particularly sheep and cattle, and to a lesser extent man, caused by infection with Bacillus anthracis. Infection takes place following the ingestion of spores, the inhalation of spores or in most cases by the entry of spores through abraded skin. The spores germinate inside macrophages and then the bacteria form a toxin which kills macrophages, increases vascular permeability and gives rise to local oedema and haemorrhage. Infection of the skin in man leads to the formation of a lesion (malignant pustule; a black eschar, hence B. anthracis; Gr. anthrakos 5 coal) consisting of a necrotic centre surrounded by vesicles, blood-stained fluid and a zone of oedema and induration. In severe infections (nearly all cases of anthrax inhalation are fatal) there is septicaemia with toxic signs, loss of fluid into tissues, with widespread oedema and eventually death. Anthrax in man occurs mainly in those whose work brings them into contact with infected animals. It is not a common disease in the United Kingdom, and the usual source of infection is imported bones, hides, skins, bristles, wool and hair, or imported fertilisers made from the blood and bones of infected animals.

The anthrax toxin complex consists of three components, factor I (EF), factor II (PA) and factor III (LF), none of which are toxic by themselves, but in binary combinations exhibit two types of activity. PA in the form PA83 binds to the receptors tumour endothelium marker-8 (TEM8) and capillary morphogenesis protein 2 (CMG2) before being proteolytically cleaved into a peptide which can form ring-shaped oligomers. Once bound to LF and EF, the complexes are endocytosed into an acidic vacuole in the cell before moving into the cytosol. PA and LF form a binary proteolytic cytotoxin which kills macrophages (see Chapter 4) but not any other cell type, whereas PA and EF form a binary toxin which will elevate cAMP levels (Figure 8 .7) in nearly all types of cell.

C. difficile represents a classic example of the difficulty in interpreting disease mechanisms in terms of characterised enzyme activities ascribed to toxins relevant in disease. C. difficile is now established as the most common nosocomial enteric pathogen causing pseudomembranous colitis, antibiotic-associated colitis and antibiotic-associated diarrhoea. The most important defence against this opportunistic pathogen is the normal colonic microflora, although the microbial species responsible for and the mechanisms whereby they suppress the growth of C. difficile are still not understood. Disruption of the normal ecosystem by antibiotics can result in colonisation by C. difficile which, if of the right pathotype, will cause diarrhoea or, more seriously, pseudomembranous colitis. Production of proteolytic and hydrolytic enzymes and capsule, expression of fimbriae and flagella, chemotaxis and adhesion to gut receptors may all play a part in the pathogenesis of C. difficile-induced disease by facilitating colonisation or by directly contributing to tissue 202 8. MECHANISMS OF CELL AND TISSUE DAMAGE damage. However, toxins A and B (TcdA, TcdB) are thought to be the primary virulence determinants of this pathogen in the context of antibiotic-associated gastrointestinal disease. The toxins have identical enzyme specificities À they glucosylate the same serine residue in target proteins, the Ras family of GTPases, leading to the disruption of vital signalling pathways within the cell. However, B is ca. 1000-fold more cytotoxic to cultured cells than A, but does not cause fluid secretion in the gut on its own, whereas A does. Over the years there has been considerable controversy in assigning relative importance to the toxins in the virulence of C. difficile. Recently it was shown using a hamster model that both toxins are capable of cytotoxicity and both toxins are important in pathogenesis. Overall, the toxins were responsible for many of the symptoms associated with C. difficile infections.

Many fungi contain substances that are harmful when taken by mouth, and there are two diseases that result from the ingestion of food containing preformed fungal toxins. As with C. botulinum, the disease is caused without the need for infection. Aspergillus flavus infects groundnuts (monkey nuts) and produces a very powerful toxin (aflatoxin). Contaminated (badly stored) groundnuts used to prepare animal feeds caused the death of thousands of turkeys and pigs in the United Kingdom in 1960 and the survivors of intoxication nearly all developed liver cancer. As such, it is now clear that these toxins can have carcinogenic properties. Human disease has not yet been associated with this toxin. Claviceps purpurae is a rust fungus affecting rye, and it produces toxins (ergotamine especially) that give rise to ergot poisoning when contaminated grain is eaten. Mushrooms and toadstools have long been recognised as sources of poisons and hallucinogens.

Unlike the toxins already discussed in this chapter, there is a group of toxins which are distinct structural components and are not released into the surrounding medium in any quantity except upon death and lysis of the bacteria. The toxins typically comprise wellrecognised structural entities which on a priori grounds must have key functions in the organism: they are found in the outer membranes of Gram-negative organisms. There are two chemically distinct types of toxin considered: lipopolysaccharide (endotoxin; LPS) and protein. The bulk of this section is taken up with endotoxin.

Many pathogenic organisms, however, are pathogenic partly by virtue of possessing various types of surface structure important in conferring virulence. These include, for example, adhesins which are important in colonising body surfaces or a variety of surface molecules (which may or may not be inside capsules) that render them resistant to phagocytosis. But the majority of adhesins and antiphagocytic determinants are themselves non-toxic.

The Gram-negative bacterial cell wall is subject to considerable variations in both the composition of LPS and in the number and nature of the proteins found in the outer-cell membrane.

Endotoxins are part of the outer membrane of Gram-negative bacteria. It has been known for many years that the cells (alive or dead) or cell extracts of a wide variety of Gram-negative bacteria are toxic to man and animals. The literature on this subject is vast, sometimes confusing and often controversial; here we can give no more than a brief outline. Some of the diseases in which endotoxin may play an important role include typhoid fever, tularaemia, plague and brucellosis, and a variety of hospital-acquired infections caused by opportunistic Gram-negative pathogens, which include E. coli, Proteus, P. aeruginosa, Enterobacter, Serratia and Klebsiella. In addition, endotoxin has been intensively studied as a possible causative agent of shock arising from post-operative sepsis or other forms of traumatic injury in which the normal flora of the gut is often the source of endotoxin.

The toxins we have considered so far have been protein (or at least part protein) in nature but, in contrast, endotoxin is a complex LPS. It is also much more heat stable than protein toxins and much less easily toxoided. In addition to lethality, endotoxin displays a bewildering array of biological effects.

The complex nature of the multilayered Gram-negative bacterial envelope is shown in Figure 8 .14 (see also Figure 4 .3). The outer membrane is composed of a bimolecular leaflet arrangement as are other membranes but has a different composition from the cytoplasmic membrane. The LPS is unique in nature, only found in Gram-negative bacteria, and is, or contains within it, what we designate endotoxin. Immunoelectron microscopy indicates that LPS exists in the outer leaflet of the membrane and extends outwards up to 300 nm; it is on, rather than in, the cell. Thus it is evident that the term endotoxin is a misnomer which derives from the era when toxins were considered to be either exotoxins, which were synthesised and secreted by the viable organism, or endotoxins, which were intracellular and released only upon lysis.

LPS consists of three regions: polysaccharide side chains, core polysaccharide, and lipid A which consists of a diglucosamine backbone to which long-chain fatty acids are linked (Figure 8 .14). The relationship of this type of molecule to the outer membrane is also shown in Figure 8 .14. The long-chain fatty acids interdigitate between the phospholipids in the outer leaflet and may also be linked (or interact) with lipoproteins, which in turn may or may not be covalently anchored to the rigid peptidoglycan. The polysaccharide side chains project outwards.

This structure is not invariant. For example, many organisms when first isolated give rise to colonies with a smooth appearance on agar but on subculture produce colonies with a rough appearance. In general, 'smooth' strains of pathogenic species are more virulent than rough strains. This S-R conversion is accompanied by a loss of region I side chains, which contain the deoxy and dideoxy sugars found in these LPS complexes. In addition to these somewhat drastic changes involving loss of side chains, it is possible to induce major compositional changes by manipulating the growth rate of these organisms in a chemostat. Thus the LPS of Salmonella enteriditis when grown with a mean generation time of 20 min is nearly totally deficient in tyvelose (a dideoxy sugar), possesses 85% of the galactose and 150% of the glucose contents of LPS obtained when the generation time is 50 min. These genotypic S organisms exhibit an R-phenotype in terms of their vastly reduced O-agglutinability (see below); such observations are potentially very important in the context of the in vivo phenotype and pathogenicity, since it is well known that the growth rate of Salmonella typhimurium in mice is 10À20 times lower than in vitro.

The extent to which lipid A is common between different genera is uncertain, but it is not likely to vary tremendously. The core polysaccharide structure is the same or very similar within groups of the Enterobacteriaciae. Thus polysaccharides from salmonellae are similar to each other, but differ from those of E. coli strains. However, within a group such as the salmonellae, there is a wide variation in the composition and detailed structures of the side chains, a fact which is exploited in the KauffmanÀWhite scheme for classifying salmonellae, giving rise to several thousand serotypes.

The side chains carry the O-somatic antigen specificities of which there are far more than can readily be accounted for on the basis of the known number of sugars involved in the basic repeating units. In the side chains are found a range of deoxy and dideoxy sugars. The general principles governing the relationship between the various chemotypes and serotypes are now well understood; the multiplicity of antibody specificities evoked may be explained in terms of antibodies which can recognise different aspects of one three-dimensional structure.

Lipid A is the primary toxiphore, but the polysaccharide plays an important part in conferring solubility upon, and optimising the size of micellar aggregates of LPS, hence affecting biological activity. However, the immune status of the test animal may affect toxicity: as normal animals produce antibodies to the antigenic determinants on the surface of normal gut organisms (including O-somatic antigens), some of the biological effects of endotoxin may be mediated by hypersensitivity mechanisms.

The range of biological properties of endotoxin is quite bewildering and the mode(s) of action very complicated. Included among those effects which might play a role in Gram-negative bacterial infections are abortion, pyrogenicity, tolerance (not immune tolerance), the Schwartzmann phenomenon, hypotension and shock, and lethality, but the precise part played by LPS in these phenomena in Gram-negative infections is far from clear. LPS causes the release of vasoactive substances, activates the alternative pathway of the complement cascade and also activates factor XII (Hageman factor), the first step of the coagulation cascade, which sometimes results in disseminated intravascular coagulation. Many, perhaps nearly all, of the actions of LPS are due to the stimulation of cytokine release from macrophages and other cells. There is an effect on the circulation, leading ultimately to vascular collapse. The vascular regions most affected differ from species to species; in man and sheep the main changes are found in the lungs. LPS has powerful immunological actions, which is surely no accident; as well as activating the complement system, it induces IL-1 production and is a potent B-cell mitogen. Man is one of the most sensitive of all species to the pyrogenic action of endotoxin. A dose of 2 ng/kg of body weight injected intravenously into man causes the release of the endogenous pyrogen IL-1 and TNF from macrophages, which act on the hypothalamus to give an elevation of body temperature within an hour. It is possible that the pyrogenic action of LPS helps to generate fever in Gram-negative bacterial infections, but LPS is not the only bacterial factor capable of inducing a febrile response. For example, recall the Gram-positive bacterial superantigens discussed earlier in this chapter.

In spite of all these toxic actions, there have been suggestions that some of the responses to LPS (by macrophages, polymorphs) could be advantageous to the host, possibly assisting in the recognition and destruction of bacteria. Could it be that host responses to LPS are, like the complement or the clotting systems, useful in moderation but harmful in excess? There are reports that, when animals with less vigorous responses to LPS are infected, they suffer fewer symptoms but permit greater growth of bacteria.

Very large numbers of Gram-negative bacteria are normally present in the intestines (see Chapter 2), their continued death and exit in the faeces being balanced by multiplication in the lumen. There is a continuous, inevitable low-grade absorption of endotoxin from the intestine. 3 Absorbed (endogenous) endotoxin enters the portal circulation and is taken up and degraded by reticuloendothelial cells, mainly Kupffer cells in the liver. Continuous exposure to endotoxin probably has profound effects on the immune system and on the histology of the intestinal mucosa, stimulating development of the immune system in the immature individual, but there are no obvious pathogenic consequences. Normal people have low levels of antibody to endotoxin as a result of this continuous exposure. The sick individual may be much more susceptible to endogenous endotoxin, perhaps because of defects in removal by Kupffer cells.

After trauma or after genito-urinary instrumentation, endotoxin is detectable in peripheral blood but this leads to no particular signs or symptoms. When large amounts of endotoxin enter the blood, there are profound effects on blood vessels with peripheral vascular pooling, a drastic fall in blood pressure, collapse and sometimes death. Thus, if enough endotoxin enters the blood during massive Gram-negative bacterial sepsis, the vasomotor action of endotoxin becomes important and shock intervenes. 4 In experimental animals endotoxin also causes vasodilation and haemorrhage into the intestinal mucosa, and sometimes haemorrhage into the placenta with abortion, but these actions do not appear to be important in all Gram-negative bacterial infections. 3 In addition, various antigens are absorbed in small quantities from the intestine, and in normal individuals antibodies are formed against various food proteins and to some extent against resident intestinal bacteria (see Chapter 2). Kupffer cells remove any antigenÀantibody complexes formed locally in the intestine and prevent them from entering the systemic circulation.

To summarise, endotoxin, although studied so carefully and for so long, has not yet been shown to play a definitive role as a toxin in the pathogenesis of any infectious disease. But, in spite of its effects on various host defence systems including polymorphs, lymphocytes, macrophages, complement, and on endothelial cells and platelets, its overall role in infection is still not clear. It can, however, cause shock when Gram-negative bacteria invade the blood. It is for this reason that considerable effort in recent years has gone into the development of antilipid A antibodies for use as therapeutic agents to combat shock in such situations; the success rate is only partial and the expense enormous. It may be feasible to develop synthetic derivatives which would neutralise the biological activity of lipid A. However, the characteristics of the O-antigen polysaccharide are sometimes important in determining virulence: certain chemotypes are important in resisting phagocytosis.

Considerable space has been given to toxins because they are being intensively investigated as possible virulence determinants and have a major impact on the pathology of infectious diseases. The account illustrates the complexity of hostÀmicrobe interactions when analysed at the molecular level. Most toxins are liberated from the microbial cell and can be studied with greater facility than many of the more elusive determinants of pathogenicity. But remember that microbes that replicate inside host cells are less likely to form powerful toxins because they cannot afford to damage at too early a stage the cell in which they are multiplying. Thus, toxins are not prominent products in intracellular infections due to Mycobacteria, Brucella, Rickettsiae, Mycoplasma or Chlamydia, and viruses do not form toxins.

Although a single molecule of a toxin-like DT is enough to kill a cell, other toxins may do no more than impair cell function when present in sublethal concentrations. This can lead, for instance, to defective function in immune or phagocytic cells. Low concentrations of the streptococcal streptolysins will inhibit leucocyte chemotaxis. At even lower concentrations the toxins can be potent inducers of cytokines. The PLY of S. pneumoniae and anthrax lethal toxin make monocytes release IL-1 and TNF-α at 10 215 and 10 218 molar concentrations, respectively.

The ability to form toxins, whether encoded by the chromosome or by plasmids, is subject to strong selective pressures. If toxin production puts a microorganism at a serious disadvantage, it will tend to disappear. If it is advantageous it will be maintained, and will spread through the microbial population, just as the genetic changes that confer resistance to anti-microbial drugs are selected for when these drugs are widely used. It is therefore not unreasonable to ask how many of the well-known toxins are actually useful to the microbe as well as being important in causing disease in the host (Table 8 .4). Although for some toxins, the specific advantage they confer to the bacteria is unclear, it is highly likely there is an important function provided which contributes to bacterial survival or transmission. The potent damaging effects of some toxins may not be representative of the true benefit which the toxin provides to the bacteria.

In infectious diseases there is nearly always a certain amount of direct microbial damage to host tissues, as discussed above. Host cells are destroyed or blood vessels injured as a direct result of the action of microbes or their toxins. Blood vessel injuries account for much of the disease picture in rickettsial infections (see above). Inflammatory materials are liberated from necrotic cells, whatever the cause of the necrosis. Also many bacteria themselves liberate inflammatory products and certain viruses cause living infected cells to release inflammatory mediators. Therefore it is not always clear how much of the inflammation is directly microbial rather than host in origin. For instance, peptidoglycan of Haemophilus influenzae type b causes acute inflammation when introduced into the cerebrospinal fluid of adult rats. Probably much of this is caused by inflammatory mediators from the host; TNF-α is detectable in cerebrospinal fluid of most cases of purulent bacterial meningitis in humans and there are raised concentrations in the serum of patients with Plasmodium falciparum malaria. But inevitably the host (see Chapter 3) generates inflammatory and other tissue responses, and these responses sometimes account for the greater part of the tissue changes. Pathological changes can then be regarded as occurring indirectly as a result of these responses to the infection. Inflammation causes redness, swelling, pain and sometimes loss of function of the affected part (see Chapter 6) and is generally a major cause of the signs and symptoms of disease. Indirect damage attributable to the host immune response is discussed separately below. In most diseases direct and indirect types of damage both make a contribution to pathological changes, but in a given disease one or the other may predominate. In a staphylococcal abscess the bacteria produce inflammatory materials, but they also kill infiltrating polymorphs whose lysosomal enzymes are thereby liberated and induce further inflammation. This type of indirect non-immunological damage is sometimes important in streptococcal infections. Virulent streptococci produce various toxins that damage phagocytes and also bear on their surfaces substances that impede phagocytosis (see Chapter 4). Nevertheless, with the help of antibody, all streptococci are eventually phagocytosed and killed and the infection terminated. Unlike the staphylococci, however, killed group A streptococci pose a digestive problem for phagocytic cells. The peptidoglycan component of the streptococcal cell wall is very resistant to digestion by lysosomal enzymes. Hence macrophages laden with indigestible streptococcal cell walls tend to accumulate in sites of infection. Lysosomal enzymes, including collagenase, leak from these macrophages, causing local destruction of collagen fibres and the connective tissue matrix. Macrophages secrete many other substances, some of which may contribute to cell and tissue damage. Many macrophages eventually die or form giant cells, sometimes giving rise to granulomatous lesions. In this way, persistent streptococcal materials sometimes cause chronic inflammatory lesions in the infected host. An additional immunopathological contribution to the lesions is to be expected if the host is sensitised to peptidoglycan components. Other pathogenic microorganisms that are digested with difficulty by phagocytes include Listeria, Shigella, Candida albicans and, of course, Mycobacteria, but the importance of this in the pathogenesis of disease is not generally clear.

The expression of the immune response necessarily involves a certain amount of inflammation, cell infiltration, lymph node swelling, even tissue destruction, as described in Chapter 6. Such changes caused by the immune response are classed as immunopathological. Sometimes they are very severe, leading to serious disease or death, but at other times they play a minimal part in the pathogenesis of disease. With the possible exception of certain vertically transmitted virus infections and the transmissible spongiform encephalopathies (prion diseases), there are signs of an immune response in all infections. Therefore it is to be expected that there will nearly always be some contribution of the immune response to pathological changes. Often the immunological contribution is small, but sometimes it forms a major part of the disease. For instance, in tuberculosis (TB) the pathological picture is dominated by the operation of a strong and persistent cell-mediated immunity (CMI) response to the invading bacillus. In the classical tubercle a central zone of bacilli with large mononuclear and giant cells, often with some necrosis, is surrounded by fibroblasts and lymphocytes. Mononuclear infiltrations, giant cells and granulomatous lesions are characteristic pathological features of TB. When macrophages are killed by intracellular mycobacteria, the lysosomal enzymes and other materials released from the degenerating cell contribute to chronic inflammation as in the case of the streptococcal lesions referred to above.

The mere enlargement of lymphoid organs during infectious diseases is a morphological change that can often be regarded as pathological. The lymph node swelling seen in glandular fever, for instance, is an immunopathological feature of the disease, and the same can be said of the striking enlargement of the spleen caused by chronic malaria and other infections in the condition known as tropical splenomegaly.

As often as not the relative importance of direct microbial damage as opposed to immune and non-immune inflammatory reactions had not yet been determined, but the picture is clearer in most of the examples given below.

In one important human disease, pathological changes are certainly immunopathological in nature, but not enough is known about it to classify the type of reaction (Table 8 .5). This disease is rheumatic fever, which follows group A streptococcal infections of the throat. It is the commonest form of heart disease in many developing countries, where it currently affects 30 million children. Antibodies formed against a streptococcal cell wall or membrane component also react with the patient's heart muscle or valves, and myocarditis develops a few weeks later. Many strains of streptococci have antigens that cross-react with the heart, and repeated infections with different streptococci cause recurrent attacks of rheumatic fever. There is genetic predisposition to the disease, based either on a particular antigen present in the heart of the patient or on a particular type of antibody response.

A number of microorganisms have antigens similar to host tissue components so that in the course of responding immunologically to such infections the host is vulnerable to autoimmune damage (e.g. ankylosing spondylitis). The antibodies to host components such as DNA, IgG, myofibrils and erythrocytes that are seen in trypanosomiasis, Mycoplasma pneumoniae, and EpsteinÀBarr virus infections appear to result from polyclonal activation of B cells. It is not clear how important these autoimmune responses are in pathogenesis, but they reflect fundamental disturbances in immunoregulation.

Four types of immunopathology can be distinguished according to the classification of allergic reactions by Coombs and Gell, and microbial immunopathology will be described under these headings (see Table 8 .5).

These depend on the reactions of antigens with reaginic (IgE) antibodies attached to mast cells via the latter's Fc receptors. The reaction takes place mostly at the body surfaces, resulting in the release of histamine, eosinophil and neutrophil chemotactic factors, leukotrienes and heparin from mast cells, and the activation of serotonin and plasma kinins. If the antigenÀantibody interaction takes place on a large enough scale in the tissue, the histamine that is released can give rise to anaphylactic shock, the exact features depending on the sensitivity and particular reaction of the species of animal to histamine. Guinea pigs suffer from bronchospasm and asphyxia, and in man there are similar symptoms, sometimes with a fall in blood pressure and shock. This type of immunopathology, although accounting for anaphylactic reactions to horse serum or to penicillin, is not important in infectious diseases. When the antigenÀIgE antibody interaction takes place at the body surface, there are local inflammatory events, giving rise to urticaria in the skin, and hay fever or asthma in the respiratory tract. This local type of anaphylaxis may play a part in the pathogenesis of virus infections of the upper respiratory tract (e.g. common cold, RSV infections of infants), or in skin rashes in infectious diseases. Type 1 reactions are common in helminth infections perhaps because IgE antibodies have an important role in protection against these parasites. The IgE antigen reaction, by causing inflammation, summons up from the blood anti-microbial forces such as polymorphs, antibodies and complement components. A dramatic Type 1 reaction can follow rupture of a hydatid cyst of Echinococcus granulosus (the dog tapeworm). Slow leakage of worm antigens means that mast cells are sensitised with specific IgE antibody, and the sudden release of antigen can cause life-threatening anaphylaxis. When the larvae of Ascaris lumbricoides pass through the lung on their journey from blood to intestine, they can give rise to IgE-mediated respiratory symptoms, with infiltration of eosinophils.

Reactions of this type occur when antibody combines with antigen on the surface of a tissue cell, and either activates the complement sequence whose membrane attack complex kills the cell, or triggers cytotoxicity by K cells (NK cells or phagocytes with Fc receptors). K (killer) cell cytolysis is referred to as antibody-dependent cellular cytotoxicity (ADCC). The antibody-coated cell is destroyed. As discussed in Chapter 6, the same reaction on the surface of a microorganism (e.g. enveloped virus) constitutes an important part of anti-microbial defences, often leading to the destruction of the microorganism. Cells infected with viruses and bearing viral antigens on their surface are destroyed in a similar way.

Clearly the antibody-mediated destruction of infected cells means tissue damage, and it perhaps accounts for some of the liver necrosis in hepatitis B, for instance, and probably in yellow fever. Infected cells can also be destroyed by sensitised lymphocytes or NK cells independently of antibody (see below).

In certain infections antibodies are formed against host erythrocytes and these cells are particularly sensitive to lysis. The haemolysis in malaria is caused by antibodies to parasitederived antigens that have attached to red cells, rather than by autoantibodies to red cells themselves. In pneumonia due to M. pneumoniae (atypical pneumonia), antibodies (cold agglutinins) are formed against normal human group O erythrocytes. Haemolytic anaemia is occasionally seen, and there is reticulocytosis (see Glossary) in 64% of patients. The lesions in the lungs are perhaps based on cell-mediated immunopathological reactions.

The combination of antibody with antigen is an important event, initiating inflammatory phenomena that are inevitably involved in the expression of the immune response. In the infected host, these inflammatory phenomena are most of the time of great antimicrobial value (see Chapter 6). But there are nevertheless immunopathological features of the infection, and immune complex reactions sometimes do a great deal of damage in the infected individual. The mechanisms by which antigenÀantibody reactions cause inflammation and tissue damage are outlined in Figure 8 .15. IgA immune complexes are generally less harmful. Antigens absorbed from the intestine can combine locally with IgA antibody and the complex then enters the blood, to be filtered out in the liver and excreted harmlessly in bile.

When the antigenÀantibody reaction takes place in extravascular tissues, there is inflammation and oedema with infiltration of neutrophils. If soluble antigen is injected intradermally into an individual with large amounts of circulating IgG antibody, the antigenÀantibody reaction takes place in the walls of skin blood vessels and causes an inflammatory response. The extravasating neutrophils degenerate and their lysosomal enzymes cause extensive vascular damage. This is the classical Arthus response. AntigenÀ antibody reactions in tissues are not usually as serious as this, and milder inflammatory sequelae are more common as in the case of allergic alveolitis (see below).

When the antigenÀantibody reaction takes place in the blood to give circulating immune complexes, the sequelae depend to a large extent on size and on the relative proportions of antigen and antibody. If there is a large excess of antibody, each antigen molecule is covered with antibody and is removed rapidly by reticuloendothelial cells, which have receptors for the Fc portion of the antibody molecule (see Chapter 4). When equal amounts of antigen and antibody combine, lattice structures are produced, and these form large aggregates whose size ensures that they are also rapidly removed by reticuloendothelial cells. If, however, complexes are formed in antigen excess, the poorly coated antigen molecules are not removed by reticuloendothelial cells. They continue to circulate in the blood and have the opportunity to localise in small blood vessels elsewhere in the body. Complexes are deposited in the glomeruli of the kidneys, the choroid plexuses, joints and ciliary body of the eye. Factors may include local high blood pressure and turbulent flow (glomeruli), or the filtering function of the vessels involved (choroid plexus, ciliary body). In the glomeruli the complexes pass through the endothelial windows (Figure 8 .16) and come to lie beneath the basement membrane. The smallest-sized complexes pass through the basement membrane and seem to enter the urine. This is probably the normal mechanism of disposal of such complexes from the body. Immune complexes are formed in many, perhaps most, acute infectious diseases. Microbial antigens commonly circulate in the blood in viral, bacterial, fungal, protozoal, rickettsial, etc. infections. When the immune response has been generated and the first trickle of specific antibody enters the blood, immune complexes are formed in antigen excess. This is generally a transitional stage soon giving rise to antibody excess, as more and more antibody enters the blood and the infection is terminated. Sometimes the localisation of immune complexes and complement in kidney glomeruli 5 is associated with a local inflammatory response after complement activation. There is an infiltration of neutrophils, swelling of the glomerular basement membrane, loss of albumin, even red blood cells, in the urine and the patient has acute glomerulonephritis. This is seen following streptococcal infections, mainly in children (see below). As complexes cease to be formed the changes are reversed, and complete recovery is the rule. Repeated attacks or persistent deposition of complexes leads to irreversible damage, often with proliferation of epithelial cells following the seepage of fibrin into the urinary space.

Under certain circumstances, complexes continue to be formed in the blood and deposited subendothelially for long periods. This happens in certain persistent microbial infections in which microbial antigens are continuously released into the blood but antibody responses are only minimal or of poor quality (see below). Complexes are deposited in glomeruli over the course of weeks, months or even years. The normal mechanisms for removal are inadequate. The deposits, particularly larger complexes containing high molecular weight antigens or antibodies (IgM), are held up at the basement membrane and accumulate in the subendothelial space together with the complement components. As deposition continues, they gradually move through to the mesangial space (Figure 8 .16) where they form larger aggregates. Mesangial cells (macrophages of the kidneys) one of whose functions is to deal with such materials, enlarge, multiply and extend into the subepithelial space. If these changes are gradual there are no inflammatory changes, but the structure of the basement membrane alters, allowing proteins to leak through into the urine. Later the filtering function of the glomerulus becomes progressively impaired. The pathological processes continue, some glomeruli ceasing to produce urine and the individual has chronic glomerulonephritis.

Circulating immune complex deposition in joints leads to joint swelling and inflammation, but in choroid plexuses there are no apparent pathological sequelae. Circulating immune complexes are also deposited in the walls of small blood vessels in the skin and elsewhere, where they may induce inflammatory changes. The prodromal rashes seen in exanthematous virus infections and in hepatitis B are probably caused in this way. If the vascular changes are more marked, they give rise to the condition called erythema nodosum, in which there are tender red nodules in the skin, with deposits of antigen, antibody and complement in vessel walls. Erythema nodosum is seen following streptococcal infections and during the treatment of patients with leprosy. When small arteries are severely affected, for instance in some patients with hepatitis B, this gives rise to periarteritis nodosa.

Immune complex glomerulonephritis occurs as an indirect immunopathological sequel to a variety of infections. First there are certain virus infections of animals. The antibodies formed in virus infections can act to neutralise any free virus particles, thus terminating the infection (see Chapter 6), but the infection must persist if antigen is to continue to be released into the blood and immune complexes formed over long periods. Non-neutralising antibodies help promote virus persistence because they combine specifically with virus particles, fail to render them non-infectious, and at the same time block the action of any 'good' neutralising antibodies that may be present. Immune complexes in antigen excess are formed in the blood when the persistent virus or its antigens circulates in the plasma and reacts with antibody which is present in relatively small amounts. Virus infections with these characteristics are included in Table 8 .6. In each instance complexes are deposited in kidney glomeruli and sometimes in other blood vessels as described above. In some there are few if any pathological changes (LDV and leukaemia viruses in mice), probably because there is a slow rate of immune complex deposition, whereas in others glomerulonephritis (LCM virus in mice, hepatitis B and C and HIV in man) or vasculitis (ADV in mink) is seen.

A persistent virus infection that induces a feeble immune response forms an ideal background for the development of immune complex glomerulonephritis and is often seen in HIV-infected patients. There are one or two other microorganisms that occasionally cause this type of glomerulonephritis, and it is seen, for instance, in chronic quartan malaria and sometimes in infective endocarditis. In both these examples microbial antigens circulate in the blood for long periods. However, immune complex deposition does not necessarily lead to the development of glomerulonephritis, and immune complexes are detectable in the glomeruli of most normal mice and monkeys. Even in persistent virus infections the rate of deposition may be too slow to cause pathological changes as with LDV and leukaemia virus infections of mice (see Table 8 .5).

Immune complex glomerulonephritis occurs in man as an important complication of streptococcal infection, but this is usually acute in nature with complement activation and inflammation of glomeruli, as referred to above. Antibodies formed against an unknown component of the streptococcus react with circulating streptococcal antigen, perhaps also with a circulating host antigen, and immune complexes are deposited in glomeruli. Streptococcal antibodies cross-reacting with the glomerular basement membrane or with streptococcal antigen trapped in the basement membrane may contribute to the picture. Deposition of complexes continues after the infection is terminated, and glomerulonephritis develops a week or two later. The streptococcal infection may be of the throat or skin, and Streptococcus pyogenes types 12 and 49 are frequently involved. Glomerulonephritis is also an important consequence of Lyme disease in dogs, caused by the tick-borne pathogen Borrelia burgdorferi. Nephrologists and pathologists distinguish 10 different types of glomerulonephritis, some of them infectious in origin, the immune complexes being deposited directly from blood or formed locally in glomeruli.

When certain antigens are inhaled by sensitised individuals and the antigen reaches the terminal divisions of the lung, there is a local antigenÀantibody reaction with formation of immune complexes. The resulting inflammation and cell infiltration causes wheezing and respiratory distress, and the condition is called allergic alveolitis. Persistent inhalation of the specific antigen leads to chronic pathological changes with fibrosis and respiratory disease. Exposure to the antigen must be by inhalation; when the same antigen is injected intradermally, there is an Arthus-type reaction, and IgG rather than IgE antibodies are involved.

There are a number of microorganisms that cause allergic alveolitis. Most of these are fungi. A disease called farmer's lung occurs in farm workers repeatedly exposed to mouldy hay containing the actinomycete Micromonospora faeni. Cows suffer from the same condition. A fungus contaminating the bark of the maple tree causes a similar disease (maple bark stripper's disease) in workers in the United States employed in the extraction of maple syrup. The mild respiratory symptoms occasionally reported after respiratory exposure of sensitised individuals to TB doubtless have the same immunopathological basis.

In addition to their local effects, antigenÀantibody complexes generate systemic reactions. For instance, the fever that occurs at the end of the incubation period of many virus infections is probably attributable to a large-scale interaction of antibodies with viral antigen, although extensive CMI reactions can also cause fever.

Systemic immune complex reactions taking place during infectious diseases can give rise to a serious condition known as disseminated intravascular coagulation. This is seen sometimes in severe generalised infections such as Gram-negative septicaemia, meningococcal septicaemia, plague, yellow fever and fevers due to hantaviruses. Immune complex reactions activate the enzymes of the coagulation cascade (Figure 8.15 ), leading to histamine release and increased vascular permeability. Fibrin is formed and is deposited in blood vessels in the kidneys, lungs, adrenals and pituitary. This causes multiple thromboses with infarcts, and there are also scattered haemorrhages because of the depletion of platelets, prothrombin, fibrinogen, etc.

Immune complex immunopathology is probable in various other infectious diseases. For instance, the occurrence of fever, polyarthritis, skin rashes and kidney damage (proteinuria) in meningococcal meningitis and gonococcal septicaemia indicates immune complex deposition. Circulating immune complexes are present in these conditions. Immune complexes perhaps play a part in the oedema and vasculitis of trypanosomiasis and in the rashes of secondary syphilis.

Although antibodies often protect without causing damage, the mere expression of a CMI response involves inflammation, lymphocyte infiltration, macrophage accumulation and macrophage activation as described in Chapter 6. The CMI response by itself causes pathological changes, and cytokines such as TNF and INF play an important part. This can be demonstrated as a delayed hypersensitivity reaction by injecting tuberculin into the skin of a sensitised individual. The CMI response to infection dominates the pathological picture in TB, with mononuclear infiltration, degeneration of parasitised macrophages and the formation of giant cells as central features. These features of the tissue response result in the formation of granulomas (see Glossary) which reflect chronic infection and accompanying inflammation. There is a ding-dong battle as the host attempts to contain and control infection with a microorganism that is hard to eliminate. The granulomas represent chronic CMI responses to antigens released locally. Various other chronic microbial and parasitic diseases have granulomas as characteristic pathological features. These include chlamydial (lymphogranuloma inguinale), bacterial (syphilis, leprosy, actinomycosis) and fungal infections (coccidiomycosis). Antigens that are disposed of with difficulty in the body are more likely to be important inducers of granulomas. Thus, although mannan is the dominant antigen of C. albicans, glucan is more resistant to breakdown in macrophages and is responsible for chronic inflammatory responses.

Fibrosis is a feature of chronic infection with some viruses such as hepatitis B, hepatitis C and EpsteinÀBarr viruses. The hepatitis viruses replicate in parencymal cells (hepatocytes) of the liver and become targeted by cytotoxic T cells. These cells fail to resolve the infection and promote chronic inflammation leading to extensive fibrosis and scar formation. Eventually this lead to liver failure and/or hepatocellular carcinoma. A similar mechanism is responsible for the condition of chronic fibrosing alveolitis.

The lymphocytes and macrophages that accumulate in CMI responses also cause pathological changes by destroying host cells. Cells infected with viruses display vitrus peptides in 10 context of MHC I on their surface and so are targets for CMI responses as described in Chapters 6 and 9. Infected cells, even if they are perfectly healthy, are destroyed by the direct action of sensitised T lymphocytes, which are demonstrable in many viral infections. In glandular fever, cytotoxic T cells react against EpsteinÀBarr virus-infected B cells to unleash an immunological civil war that is especially severe in adolescents and young adults. Antigens from Trypanosoma cruzi are known to be adsorbed to uninfected host cells, raising the possibility of autoimmune damage in Chagas' disease, caused by this parasite. 6 It is also becoming clear that cells infected with certain protozoa (e.g. Theileria parva in bovine lymphocytes) have parasite antigens on their surface and are susceptible to this type of destruction. Little is known about intracellular bacteria.

The most clearly worked out example CMI mediated immunopathology is seen in LCM virus infection of adult mice. When virus is injected intracerebrally into adult mice, it grows in the meninges, ependyma and choroid plexus epithelium, but the infected cells do not show the slightest sign of damage or dysfunction. After 7À10 days, however, the mouse develops severe meningitis with submeningeal and subependymal oedema, and 6 Chagas' disease, common in Brazil, affects 12 million people and is transmitted by blood-sucking insects. After spreading through the body during the acute infection, the parasitaemia falls to a low level and there is no clinical disease. Years later a poorly understood chronic disease appears, involving heart and intestinal tract, which contain only small numbers of the parasite but show a loss of autonomic ganglion cells. An autoimmune mechanism is possible, because a monoclonal antibody to T. cruzi has been obtained that cross-reacts with mammalian neurons. dies. The illness can be completely prevented by adequate immunosuppression, and the lesions are attributable to the mouse's own vigorous CD8 1 T-cell response to infected cells. These cells present processed LCM viral peptides on their surface in conjunction with MHC class I proteins, and sensitised CD8 1 T cells, after entering the cerebrospinal fluid and encountering the infected cells, generate the inflammatory response and interference with normal neural function that cause the disease. The same cells destroy infected tissue cells in vitro, but tissue destruction is not a feature of the neurological disease. In this disease the CD8 1 T cells probably act by liberating inflammatory cytokines. It may be noted that the brain is uniquely vulnerable to inflammation and oedema, as pointed out earlier in this chapter. The infected mouse shows the same type of lesions in scattered foci of infection in the liver and elsewhere, but they are not a cause of sickness or death. LCM infection of mice is a classical example of immunopathology in which death itself is entirely due to the cell-mediated immune response of the infected individual. This response, although apparently irrelevant and harmful, is nevertheless an 'attempt' to do the right thing. It has been shown that immune T cells effectively inhibit LCM viral growth in infected organs. However, a response that in most extraneural sites would be useful and appropriate turns out to be self-destructive when it takes place in the CNS.

Another type of T-cell-mediated immune pathology is illustrated by influenza virus infection of the mouse. When inoculated intranasally, the virus infects the lungs and causes a fatal pneumonia in which the airspaces fill up with fluid and cells. The reaction is massive and the lungs almost double in weight. Effectively the animal drowns. The cause is an influx of virus-specific CD8 1 T cells. Normally when an appropriate number of T cells had entered the lungs, the T cells would issue a feedback response to prevent such overaccumulation, but it is thought that influenza virus infects the T cells and inhibits this control process, so that the lungs are eventually overwhelmed. The virus does not multiply in or kill the infected T cells, and it is presumed that it undergoes limited gene expression.

One human virus infection in which a strong CMI contribution to pathology seems probable is measles. Children with thymic aplasia show a general failure to develop T lymphocytes and CMI, but have normal antibody responses to most antigens. They suffer a fatal disease if they are infected with measles virus. Instead of the limited extent of virus growth and disease seen in the respiratory tract in normal children, there is inexorable multiplication of virus in the lung, in spite of antibody formation, giving rise to giant cell pneumonia. This indicates that the CMI response is essential for the control of virus growth. In addition there is a total absence of the typical measles rash, and this further indicates that the CMI response is also essential for the production of the skin lesions. Cell-mediated immune responses also make a contribution to the rashes in poxvirus infections.

Sometimes in infectious diseases, there are prominent pathological changes which are not attributable to the direct action of microbes or their toxins, nor to inflammation or immunopathology. The stress changes mediated by adrenal cortical hormones come into this category. Stress is a general term used to describe various noxious influences and includes cold, heat, starvation, injury, psychological stress and infection. An infectious disease is an important stress, and corticosteroids are secreted in large amounts in severe infections. They generally tend to inhibit the development of pathological changes, but also have pronounced effects on lymphoid tissues, causing thymic involution and lymphocyte destruction. These can be regarded as pathological changes caused by stress. It was the very small size of the thymus gland as seen in children dying with various diseases, especially infectious diseases, that for many years contributed to the neglect of this important organ, and delayed appreciation of its vital role in the development of the immune system.

Appreciation of the effects of stress on infectious diseases and the immune response in particular has led to the establishment of the science of neuroimmunology. Properly controlled experiments are difficult to mount but it is clear that the nervous system affects the functioning of the immune system. The pathways of this communication are still poorly understood, but there is a shared language for immune and neural cells. For example, neural cells as well as immune cells have receptors for interleukins, and lymphocytes and macrophages secrete pituitary growth hormone. Work on Mycobacterium bovis grew out of observations from the turn of the century that stress appears to increase the death rate in children with TB. In one type of experiment, mice were stressed by being kept in a restraining device where movement was virtually impossible. This resulted in the reduction of expression of MHC class II antigens on macrophages, which correlated with increased susceptibility to infection. Similarly stressing mice infected with influenza virus caused several immunosuppressive events including reduction of inflammatory cells in the lung and decreased production of IL-2. Suppression of antibody responses is found in people suffering a type of stress familiar to studentsÀexaminations! The best responses to hepatitis B vaccine in students immunised on the third day of their examinations were found in those who reported the least stress. Finally, in a double-blind trial at the Common Cold Research Unit in England with five different respiratory viruses, it was ascertained in human volunteers that stress gave a small but statistically significant increased likelihood of an individual developing clinical disease.

Pathological changes are sometimes caused in an even more indirect way as in the following example. Yellow fever is a virus infection transmitted by mosquitoes and in its severest form is characterised by devastating liver lesions. There is massive mid-zonal liver necrosis following the extensive growth of virus in liver cells, resulting in the jaundice that gives the disease its name. Destruction of the liver also leads to a decrease in the rate of formation of the blood coagulation factor, prothrombin, and infected human beings or monkeys show prolonged coagulation and bleeding times. Haemorrhagic phenomena are therefore characteristic of severe yellow fever, including haemorrhage into the stomach and intestine. In the stomach the appearance of blood is altered by acid, and the vomiting of altered blood gave yellow fever another of its names, 'black vomit disease'. Haemorrhagic phenomena in infectious diseases can be due to direct microbial damage to blood vessels, as in certain rickettsial infections or in the virus infection responsible for haemorrhagic disease of deer. They may also be due to immunological damage to vessels as in the Arthus response or immune complex vasculitis, to any type of severe inflammation, and to the indirect mechanism illustrated above. Finally there are a few infectious diseases in which platelets are depleted, sometimes as a result of their combination with immune complexes plus complement, giving thrombocytopenia and a haemorrhagic tendency (see also disseminated intravascular coagulation, p. 287). Thrombocytopenic purpura is occasionally seen in congenital rubella and in certain other severe generalised infections.

Infection during pregnancy can lead to foetal damage or death not just because the foetus is infected, but also because of infection and damage to the placenta. This is another type of indirect pathological action. Placental damage may contribute to foetal death during rubella and cytomegalovirus infections in pregnant women.

Certain viruses and even some bacteria undoubtedly cause cancer (leukaemia viruses, human papillomaviruses, several herpes viruses in animals, H. pylori-see Table 8 .1) and this is to be regarded as a late pathological consequence of infection. Sometimes the host cell is transformed by the virus and converted into a tumour cell, the virus either introducing a transforming gene into the cell, activating expression of a pre-existing cellular gene or inactivating the cell's own fail-safe tumour suppressor gene. DNA viruses require the cell to provide the nucleotides etc. required for new virus genomes and so have evolved proteins, which are necessary for virus replication, to drive the cell into S phase, where such 'building blocks' are produced. In the normal life cycle of these viruses, the cell will die as the virus completes its life cycle; however, in abortive infections where cell lysis occurs, these cells can continue to proliferate and transformation is often therefore an 'accidental' consequence of infection. The transforming genes of retroviruses are known as viral onc (vONC) genes. These vONC genes themselves originate from cellular oncogenes (cONC) which were taken up (transduced) into the genome of infecting viruses during infection. cONC are essential genes expressed within the host cell, where they play a role in normal growth and differentiation, often coding for recognised growth factors (e.g. human platelet-derived growth factor). The expression of these cellular genes is normally very tightly controlled; however, following transduction by a retrovirus they come under the control of the highly active virus promoter (LTR) and are expressed in infected cells. Additionally these transduced genes can be mutated within the virus-forming chimeric proteins with virus proteins, the net effect of this is to remove post-translational control of the activity of these proteins resulting in not only overexpression but constitutive activation.

Transformation has been extensively studied in vitro, and the features of the transformed cell have been described (changed surface and social activity, freedom from the usual growth restraints).

Increasingly, it is becoming appreciated that simultaneous infection with two different microorganisms is a relatively common occurrence. Although some infections generate antimicrobial responses such as interferon production and macrophage activation which would make a second infection less likely, co-infections are most common when local defences have been damaged by the first invader. The pathological results may be much more severe because there is a second infectious agent present. This can be considered as another mechanism of pathogenicity. Classical instances involve the respiratory tract. The destruction of ciliated epithelium in the lung by viruses such as influenza or measles allows normally non-pathogenic resident bacteria of the nose and throat, such as the pneumococcus or H. influenzae, to invade the lung and cause secondary pneumonia. If these bacteria enter the lung under normal circumstances, they are destroyed by alveolar macrophages or removed by the mucociliary escalator. In at least one instance the initial virus infection appears to act by interfering with the function of alveolar macrophages. Mice infected with parainfluenza 1 (Sendai) virus show greatly increased susceptibility to infection with H. influenzae, and this is largely due to the fact that alveolar macrophages infected with virus show a poor ability to phagocytose and kill the bacteria. Specialised respiratory pathogens such as influenza, measles, parainfluenza or rhinoviruses damage the nasopharyngeal mucosa and can lead in the same way to secondary bacterial infection, with nasal catarrh, sinusitis, otitis media or mastoiditis. The normal microbial flora of the mouth, nasopharynx or intestine is always ready to cause trouble if host resistance is lowered, but under normal circumstances they hinder rather than help other infecting microorganisms (see Chapter 2).

One interesting example of exacerbation of infection occurs in mice dually infected with influenza virus and microorganisms such as S. aureus or H. influenzae. Under these conditions, animals with an existing influenza infection are more susceptible to secondary infections with S. aureus. It is considered that a major cause of mortality in the great 1918 flu pandemic was severe pneumonia due to secondary infection with S. aureus. For an influenza virion to be infectious, the viral haemagglutinin protein needs to be proteolytically cleaved by a host protease. If the appropriate protease is in short supply or lacking completely, virions are formed but they are not infectious. Under these circumstances, the haemagglutinin can be cleaved extracellularly by microbial proteases with resulting increased amounts of infectious virus and disease. It has been shown that S. aureus can produce proteases which may activate the influenza haemagglutinin and exacerbate infection.

As a final example of dual infections, microorganisms that cause immunosuppression can activate certain pre-existing chronic infections. In measles, for instance, there is a temporary general depression of CMI; tuberculin-positive individuals become tuberculin negative, and in patients with TB the disease is exacerbated. In the acquired immunodeficiency syndrome (AIDS) immunosuppression by HIV activates a variety of pre-existing persistent infections.

In the context of the damage inflicted on the host during infection, diarrhoea deserves a separate section, since it is one of the commonest types of illness in developing countries and a major cause of death in childhood. Particularly in infants, who have a very high turnover of water relative to their size, the loss of fluid and salt soon leads to lifethreatening illness. In 1998, diarrhoea was responsible for 2.2 million deaths worldwide in children under five years old. In villages in West Africa and Guatemala, the average 2À3-year-old child has diarrhoea for about two months in each year. 7 Diarrhoea also 7 Diarrhoea on a massive scale is not always confined to developing countries. There was a major outbreak of Cryptosporidium infection in Milwaukee, United States, in 1993 with more than 400,000 cases; 285 of these were diagnosed in the laboratory and they suffered watery diarrhoea (a mean of 12 stools a day) for a mean of nine days. The small (4À5 μm) oocysts, probably from cattle, had entered Lake Michigan and then reached the community water supply because of inadequate filtration and coagulation treatment.

interacts with malnutrition and can cause stunted growth, defective immune responses and susceptibility to other infections. Fluid and electrolyte replacement is a simple, highly effective, life-saving treatment that can be used without determining the cause of the diarrhoea. Oral rehydration therapy (ORF) means giving a suitable amount of salt and sugar in clean water, and this is something that can be done by the mother. Diarrhoea is also a common affliction of travellers from developed countries, and business deals, athletic successes and holiday pleasures can be forfeited on the toilet seats of foreign lands. The most reliable prophylaxis is to 'cook it, peel it, or forget it'. Most attacks of diarrhoea are selflimiting. Diarrhoea means the passage of liquid faeces, 8 or faeces that take the shape of the receptacle rather than have their own shape. This could arise because of increased rate of propulsion by intestinal muscles, giving less time for reabsorption of water in the large bowel, or because there was an increase in the amount of fluid held or produced in the intestine. In many types of infectious diarrhoea, the exact mechanism is not known. Diarrhoea, on the one hand, can be regarded as a microbial device for promoting the shedding and spreading of the infection in the community, or, on the other hand, as a host device to hasten expulsion of the infectious agent. Diarrhoea is a superb mechanism for the dissemination of infected faeces and there is no doubt that strains of microbes are selected for their diarrhoea-producing powers. The advantages to the host of prompt expulsion of the infectious agent were illustrated when volunteers infected with Shigella flexneri were given Lomotil, a drug that inhibits peristalsis. They were more likely to develop fever and had more difficulty in eliminating the pathogen.

Before attempting to explain the pathophysiology of diarrhoeal disease, the normal structure and function of gut will be considered. The main function of the gut is the active inward transport of ions and nutrient solutes which is followed by the passive movement of water. The driving force is the Na 1 /K 1 ATPase situated in the basolateral membrane of enterocytes on the villus (), which maintains a low intracellular (Na 1 ), thus creating the electrochemical gradient favourable for Na 1 entry and a high regional (Na 1 ) in the intercellular spaces; C1 2 follows Na 1 . A similar situation exists in crypt cells: Na 1 /K 1 ATPase drives secretion. The key difference is the location of the carrier systems responsible for the facilitated entry of the actively transported species. In villus cells the carriers are present in the brush border, whereas in crypt cells they are located in the basal membrane: this is responsible for the vectorial aspects of ion/fluid traffic in villus/crypt assemblies. However, it is clear that several factors in addition to enterocytes are involved in regulating fluid transport in the gut; these include the enteric nervous system and the anatomy of the microcirculation. The latter plays a profoundly important role in the uptake of fluid. This is illustrated in Figure 8 .17, which shows the existence of zones of graded osmotic potential. At the tips of villi in adult human gut, osmolalities range from 700 to 800 mOsm/kg H 2 O, which would generate huge osmotic forces. Thus, current perceptions are that enterocytes are responsible for generating this gradient and the blood supply acts as a countercurrent multiplier which amplifies the gradient in a manner analogous to the loops of Henle in the kidney. The hypertonic zone has been demonstrated directly in whole villi of infant mice in terms of the changing morphology of erythrocytes: in the lower regions of villi they show characteristic discoid morphology, whereas in the upper region they are crenated, indicating a hyperosmotic environment. The hypertonicity is dissipated if the blood flow is too slow and washed out if too fast. It is the villus unit rather than enterocytes by themselves that is responsible for fluid uptake. Another consequence of the microcirculatory anatomy is that villus tip regions are relatively hypoxic. In addition, neonatal brush borders contain disaccharidases (principally lactase) which break down non-absorbable disaccharides (e.g. lactose) into constituent absorbable monosaccharides.

Villus tips and crypts are regarded as the anatomical sites of physiological absorption and secretion respectively. Fluid transport is a bidirectional process in the healthy animal with net absorption in health and net secretion in disease. The balance between absorption and secretion is poised at different points throughout the intestinal tract, reflecting differences in both structure and function. Proximal small intestine is relatively leaky; in contrast the colon is a powerfully absorptive organ.

Finally, crypts are the principal sites of cell regeneration, replacing cells which migrate up the epithelial escalator. The epithelium is renewed in approximately 3À5 days. At villus tips senescent cells are shed.

Diarrhoeal disease can result from interference with almost anyone, or a combination of these systems. The range of intestinal pathogens and the types of disease they cause is illustrated in Tables 8.7 and 8.8. Non-invasive pathogens like V. cholerae and enterotoxigenic E. coli (ETEC) secrete toxins which perturb the ion transport systems. Invasive nonhistotoxic pathogens, such as some Salmonella strains (see Chapter 2) and rotavirus, invade villus tip cells which are then shed into the intestinal lumen. Invasive histotoxic pathogens, such as some strains of Salmonella (see Chapter 2), cause rapid toxin-mediated Movement of sodium into VR creates a concentration gradient between VR and AV, causing absorption of water from AV and surrounding tissue. This results in a progressive increase in the osmolarity of incoming blood moving into the tip region through to VR. Tip osmolarity is about three times higher than normal. Hyperosmolarity has been demonstrated in man and can be inferred in mice from the morphology of erythrocytes which changes during ascent of the same vessel from base to tip regions of villi. The intensity of shading indicates a vertical increase in osmolarity. The left crypt represents normal physiological secretion and the right crypt hypersecretion. ENS, the enteric nervous system, is depicted schematically and not anatomically. detachment of epithelial cells. Experimental rotavirus infections have been studied in great detail allowing us to delineate intermediate stages between initial infection, through clinical diarrhoea to recovery from infection. Campylobacter jejuni does not figure in our treatment so far despite the fact that C. jejuni and related species are the most common bacterial cause of diarrhoea in many industrialised countries. It is known that motility and adherence are critical stages of infection which then lead to cytoskeletal rearrangement, host cell death, and then tight junction disruption and cytokine induction which results in loss of epithelial cell function. This then leads to a disrupted barrier, poor absorptive functions and ultimately the symptoms of disease. The clinical picture of the pathogenesis of C. jejuni infection may be summarised as follows. In developing countries the most common clinical presentation is mild watery diarrhoea, whereas in developed countries disease often manifests as a severe inflammatory diarrhoea. No evidence has yet been found to suggest that the watery type and severe bloody type of diarrhoeas can be explained in terms of a C. jejuni equivalent of the ETEC and EHEC mechanisms described above. Current thinking proposes that the different disease patterns reflect the immunological status of the host. Those with full immunity experience no clinical disease, whereas those with no pre-immunity experience the full-blown bloody diarrhoea and those with partial immunity, watery diarrhoea. The incubation period can range from 1À7 days and acute diarrhoea can last for 1À2 days with abdominal pain which may persist after diarrhoea has stopped. Diarrhoeal stools often contain fresh blood, mucus and an inflammatory exudate with leucocytes; bacteremia may also occur though it is rarely reported. Infected mucosae may be oedematous and hyperaemic with petechial haemorrhages. The disease, even its severe form, tends to be self-limiting, despite the fact that organisms may be isolated for several weeks after resolution of the symptoms. We do, however, know that there is a strong correlation between infection with C. jejuni and GuillainÀBarré syndrome which is the most notable complication of C. jejuni infection. GuillainÀBarré syndrome is a peripheral neuropathy, and one possible cause may be an autoimmune phenomenon arising from molecular mimicry between the polysaccharide side chains of C. jejuni and neural gangliosides. 9 Rotaviruses are known to invade intestinal epithelial cells and cause diarrhoea in man, foals, dogs, pigs, mice, etc. Extensive multiplication takes place and very large amounts of virus (10 11 particles/g) are shed in faeces. The conventional wisdom is that tips of villi especially are affected, leading to reduced absorption of fluid from the lumen. In addition, destruction of enterocytes leads to a loss in lactase resulting in an accumulation of lactose in the gut causing an osmotic flux of fluid into the intestine. A major study of rotavirus-induced There are more than 1,000 serotypes of Salmonella, distinct from Salmonella typhi and Salmonella paratyphi. They are primarily parasites of animals, ranging from pythons to elephants, and their importance for man is their great tendency to colonise domestic animals. Pigs and poultry are commonly affected, and human disease follows the consumption of contaminated meat or eggs. b Other campylobacters cause sepsis, abortion and enteritis in animals. diarrhoea in neonatal mice provides a different model of this important disease of children.

The main features of this model are summarised in Figure 8 .18. Oral infection of the gut induces ischaemia in villi, followed by hypoxia, enterocyte damage, and shortening of villi. The perception is that it is the induction of ischaemia and not viral replication per se that results in these changes. It is during rapid resynthesis of the atrophied villi that maximum progression. This represents a schematic summary of the text on diarrhoeal disease. diarrhoea occurs due to the transient accumulation of excess NaCl in dividing cells. Unusually for viruses, an enterotoxin has been isolated which is the product of one of the viral genes (NSP4). Administration of NSP4 alone has been shown to cause a dose-dependent diarrhoea. NSP4 has been shown to block the apical sodium glucose symporter in rabbits, contributing to the Na imbalance. Prolongation of diarrhoea is seen to be due to the hyperaemic state of the newly reconstructed villi which reduces the hypertonicity of villi. Resolution of the diarrhoea occurs when microcirculation is restored to normal with concomitant restoration of hypertonic tip zones in villi. The preceding description of the self-limiting diarrhoea induced by rotavirus in neonatal mice is that of a basic response probably applicable to many diarrhoeas, since the features of the post-peak phase have often been reported or can be inferred in other infections. However, the observed pathology will be different according to age, host species, or the inducing pathogen. For example, in rotavirus-infected lambs, villus atrophy and crypt hypertrophy occur (the latter indicative of crypt cell division) but as in mice, infected lambs are not lactose intolerant. In rotavirus-infected swine piglets, crypt hypertrophy occurs but villus atrophy is severe, the animals are lactose intolerant and mortality is high; a similar situation exists for the coronavirus, transmissible gastroenteritis (TGE) virus of swine. The latter has often been used as the model for infantile diarrhoea but the question is whether human infants are more like piglets or lambs. Clinical studies have shown that recovery from mild, acute gastroenteritis of rotavirus origin occurs within two weeks irrespective of the carbohydrate ingested. Clearly, the severity of disease and the clinical outcome will depend on the extent of 'vertical' villus/crypt involvement and the regions of intestine infected. When villus erosion is severe, then lactose may cause an 'osmotic' purge or be fermented by intestinal bacteria to short-chain fatty acids which stimulate secretion in the colon. Astroviruses, Norwalk virus, caliciviruses and certain adenoviruses all cause gastroenteritic disease by infecting enterocytes. However, parvoviruses cause severe intestinal disease in dogs by virtue of their predilection for the mitotically active crypt cells which is the cause of the nearcomplete erosion of villi similar to that seen after exposure to sublethal doses of irradiation.

Entamoeba histolytica causes lysis of target cells apparently by direct contact with the cell membrane. This pathogen produces under in vitro conditions an array of virulence determinants including the GAL/GALNac lectin involved in initial adherence, Kerp1 and 2 involved in liver abscess formation, glycosylphosphatidylinositol (GPI)-anchored lipophosphoglycans (LPGs) and cysteine proteases that round up cells, pore-forming proteins, collagenases and oligosaccharidases and neurotransmitter-like compounds; the latter can induce intestinal fluid secretion.

Although much research has been focused on toxins, their mode of action, and their role in disease, it is useful to compare different types of intestinal infection and to refer to the concept of food poisoning. Types of intestinal infection are set out in Table 8 .8. Food poisoning is a loosely used term, and usually refers to illnesses caused by preformed toxins in food, or sometimes to illnesses that come on within a day or so after eating contaminated food. Food may be contaminated with plant poisons, fungal poisons (e.g. poisoning due to Amanita phalloides), fish poisons, 10 heavy metals, as well as with bacterial toxins or bacteria. 10 Ingestion of scombroid fish (mackerel, etc.) containing large amounts of histamine or similar substances leads to headache, flushing, nausea and vomiting within an hour.

Clostridial actin-ADP-ribosylating toxins

The Comprehensive Sourcebook of Bacterial Protein Toxins

Staphylococcus aureus α-toxin: nearly a century of intrigue

EpsteinÀBarr virus and Burkitt lymphoma

Anthrax toxin

Neuroimmune interactions in stress

PhageÀbacterial interactions in the evolution of toxigenic Vibrio cholerae

Virulence and virulence factors in Entamoeba histolytica, the agent of human amoebiasis

Viral trigger for type 1 diabetes: pros and cons

ADP-ribosylation of signal-transducing guanine nucleotide-binding proteins by pertussis toxin

Pertussis pathogenesis À what we know and what we don't know

A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria

Epidemiology and host spectrum of Borna disease virus infections

Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease

General aspects and recent advances on bacterialprotein toxins

Role of pore-forming toxins in bacterial infectious diseases. Microbiol

Entry of ADP-ribosylating toxins into cells

Molecular studies of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae as an aid to vaccine design

Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis

HostÀpathogen interactions in streptococcal immune sequelae

Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies

The blockade of the neurotransmitter release apparatus by botulinum neurotoxins

Phenol-soluble modulins and staphylococcal infection

Gram-positive and Gram-negative bacterial toxins in sepsis: a brief review

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc

Staphylococcal and streptococcal superantigen exotoxins

Bacterial Toxins

The unfolding story of anthrax toxin translocation

The development of respiratory syncytial virus-specific IgE and the release of histamine in naso-pharyngeal secretions after infection

Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum

Immune complexes in human diseases

Clostridial neurotoxins À proposal of a common nomenclature